CLK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O43852 | S300 | Sugiyama | CALU | NKDGKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF_____ |
| O43852 | T303 | Sugiyama | CALU | GKLTKEEIVDKyDLFVGsQAtDFGEALVRHDEF________ |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60829 | S7 | EPSD|PSP | PAGE4 GAGEC1 JM27 | ______________MSARVRsRsRGRGDGQEAPDVVAFVAP |
| O60829 | S73 | EPSD|PSP | PAGE4 GAGEC1 JM27 | PIEERKVEGDCQEMDLEKtRsERGDGsDVKEKtPPNPKHAK |
| O60829 | S79 | EPSD|PSP | PAGE4 GAGEC1 JM27 | VEGDCQEMDLEKtRsERGDGsDVKEKtPPNPKHAKtKEAGD |
| O60829 | S9 | EPSD|PSP | PAGE4 GAGEC1 JM27 | ____________MSARVRsRsRGRGDGQEAPDVVAFVAPGE |
| O60829 | T51 | EPSD|PSP | PAGE4 GAGEC1 JM27 | QQEEPPTDNQDIEPGQEREGtPPIEERKVEGDCQEMDLEKt |
| O60829 | T71 | EPSD|PSP | PAGE4 GAGEC1 JM27 | tPPIEERKVEGDCQEMDLEKtRsERGDGsDVKEKtPPNPKH |
| O60829 | T85 | EPSD|PSP | PAGE4 GAGEC1 JM27 | EMDLEKtRsERGDGsDVKEKtPPNPKHAKtKEAGDGQP___ |
| O60829 | T94 | EPSD|PSP | PAGE4 GAGEC1 JM27 | ERGDGsDVKEKtPPNPKHAKtKEAGDGQP____________ |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P10809 | T381 | Sugiyama | HSPD1 HSP60 | KGDKAQIEKRIQEIIEQLDVttsEyEKEKLNERLAKLsDGV |
| P10809 | Y385 | Sugiyama | HSPD1 HSP60 | AQIEKRIQEIIEQLDVttsEyEKEKLNERLAKLsDGVAVLK |
| P18031 | S242 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | PTPN1 PTP1B | SGTFCLADTCLLLMDKRKDPssVDIKKVLLEMRKFRMGLIQ |
| P18031 | S243 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | PTPN1 PTP1B | GTFCLADTCLLLMDKRKDPssVDIKKVLLEMRKFRMGLIQT |
| P18031 | S50 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | PTPN1 PTP1B | FPCRVAKLPKNKNRNRyRDVsPFDHSRIKLHQEDNDyINAs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P49760 | S142 | GPS6|SIGNOR|EPSD|Sugiyama | CLK2 | RRRSRtFSRSSSQHSSRRAKsVEDDAEGHLIYHVGDWLQER |
| P49760 | S167 | Sugiyama | CLK2 | AEGHLIYHVGDWLQERYEIVsTLGEGtFGRVVQCVDHRRGG |
| P49760 | S426 | Sugiyama | CLK2 | RKTRKQKYFYRGRLDWDENTsAGRyVRENCKPLRRYLTSEA |
| P49760 | S98 | GPS6|EPSD | CLK2 | RRNDYSRDRGDAYyDTDYRHsYEyQRENSSYRSQRSSRRKH |
| P49760 | T173 | Sugiyama | CLK2 | YHVGDWLQERYEIVsTLGEGtFGRVVQCVDHRRGGARVALK |
| P49760 | Y430 | Sugiyama | CLK2 | KQKYFYRGRLDWDENTsAGRyVRENCKPLRRYLTSEAEEHH |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13242 | S216 | Sugiyama | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q14004 | S383 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | sRRRSPSYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVL |
| Q14004 | S385 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | RRSPSYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVLRR |
| Q14152 | S1188 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PWRPLVKPGGWREKEKAREEsWGPPRESRPsEEREWDREKE |
| Q14978 | S686 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | KGKSFRHEKTKKKRGsYRGGsIsVQVNsIKFDsE_______ |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96MU7 | S308 | Sugiyama | YTHDC1 KIAA1966 YT521 | GSGTDGsDEKKKERKRARGIsPIVFDRsGssAsESYAGsEK |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q96T37 | S670 | Sugiyama | RBM15 OTT OTT1 | GRHLDRsPEsDRPRKRHCAPsPDRsPELsssRDRYNsDNDR |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9NRR4 | S217 | Sugiyama | DROSHA RN3 RNASE3L RNASEN | NNSSSPHFRHLPPYPLPKAPsERRsPERLKHYDDHRHRDHS |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | T856 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFEss |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 6.522434e-10 | 9.186 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 8.677769e-08 | 7.062 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.022874e-07 | 6.990 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.609405e-07 | 6.793 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.289060e-07 | 6.368 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.898395e-07 | 6.310 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.332110e-07 | 6.198 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.173629e-06 | 5.930 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.792585e-06 | 5.554 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.105619e-06 | 5.214 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.129629e-05 | 4.947 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.136396e-05 | 4.670 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.345984e-05 | 4.198 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.322069e-04 | 3.634 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.761592e-04 | 3.425 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.498504e-04 | 3.347 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 4.328786e-04 | 3.364 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.094939e-04 | 3.293 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.379410e-04 | 3.269 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 6.226928e-04 | 3.206 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 6.344531e-04 | 3.198 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.709313e-04 | 3.173 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.999889e-04 | 3.155 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.039475e-04 | 3.095 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.164307e-04 | 3.088 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 7.917016e-04 | 3.101 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.051127e-03 | 2.978 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.078414e-03 | 2.967 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.090875e-03 | 2.962 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.082382e-03 | 2.966 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.158719e-03 | 2.936 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.269795e-03 | 2.896 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.253250e-03 | 2.902 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.342080e-03 | 2.872 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 1.469718e-03 | 2.833 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.469718e-03 | 2.833 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.427383e-03 | 2.845 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.445694e-03 | 2.840 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.445694e-03 | 2.840 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.537460e-03 | 2.813 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.575470e-03 | 2.803 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.027198e-03 | 2.693 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.727953e-03 | 2.564 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.730685e-03 | 2.564 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.024718e-03 | 2.519 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.972440e-03 | 2.527 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.972440e-03 | 2.527 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.057513e-03 | 2.515 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.235867e-03 | 2.490 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.322226e-03 | 2.479 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 3.473515e-03 | 2.459 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 3.473515e-03 | 2.459 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 3.618336e-03 | 2.441 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.630474e-03 | 2.440 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.329523e-03 | 2.364 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.383383e-03 | 2.358 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.669913e-03 | 2.331 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.950590e-03 | 2.305 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.950590e-03 | 2.305 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.883600e-03 | 2.311 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.941788e-03 | 2.306 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.307534e-03 | 2.200 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 6.968374e-03 | 2.157 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.039182e-03 | 2.152 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.298087e-03 | 2.137 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.464576e-03 | 2.127 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.139829e-03 | 2.089 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.046558e-03 | 2.094 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.348355e-03 | 2.078 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.348355e-03 | 2.078 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.714622e-03 | 2.060 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.714622e-03 | 2.060 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.348355e-03 | 2.078 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 9.380261e-03 | 2.028 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.806949e-03 | 2.008 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.004106e-02 | 1.998 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.004334e-02 | 1.998 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.082422e-02 | 1.966 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.327271e-02 | 1.877 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.367979e-02 | 1.864 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.484435e-02 | 1.828 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.484435e-02 | 1.828 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.403731e-02 | 1.853 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.451366e-02 | 1.838 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.535712e-02 | 1.814 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.573087e-02 | 1.803 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.587483e-02 | 1.799 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.705793e-02 | 1.768 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.785595e-02 | 1.748 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.903047e-02 | 1.721 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 1.959196e-02 | 1.708 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.959196e-02 | 1.708 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 1.959196e-02 | 1.708 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.969733e-02 | 1.706 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.128986e-02 | 1.672 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.017255e-02 | 1.695 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.060772e-02 | 1.686 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.133506e-02 | 1.671 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.209010e-02 | 1.656 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.260982e-02 | 1.646 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.370841e-02 | 1.625 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.370841e-02 | 1.625 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.380906e-02 | 1.623 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.591836e-02 | 1.586 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.529053e-02 | 1.597 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.654392e-02 | 1.576 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.654392e-02 | 1.576 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.654392e-02 | 1.576 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.934836e-02 | 1.532 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.981427e-02 | 1.526 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.479969e-02 | 1.458 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.479969e-02 | 1.458 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.223809e-02 | 1.492 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.479969e-02 | 1.458 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.465756e-02 | 1.460 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.495699e-02 | 1.456 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.495754e-02 | 1.456 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.499610e-02 | 1.456 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.632117e-02 | 1.440 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.666470e-02 | 1.436 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.761574e-02 | 1.425 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.793209e-02 | 1.421 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 4.492862e-02 | 1.347 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.482870e-02 | 1.348 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.288915e-02 | 1.368 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.649372e-02 | 1.333 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.122743e-02 | 1.290 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.122743e-02 | 1.290 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.122743e-02 | 1.290 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.940209e-02 | 1.306 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.914769e-02 | 1.308 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.725042e-02 | 1.326 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.745570e-02 | 1.324 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.984351e-02 | 1.302 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.122743e-02 | 1.290 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.745570e-02 | 1.324 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.857983e-02 | 1.314 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.857983e-02 | 1.314 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.735010e-02 | 1.325 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.735010e-02 | 1.325 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.745570e-02 | 1.324 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.307560e-02 | 1.275 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.349005e-02 | 1.272 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 5.443053e-02 | 1.264 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 5.443053e-02 | 1.264 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.443053e-02 | 1.264 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.443053e-02 | 1.264 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.529718e-02 | 1.257 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.264769e-02 | 1.203 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.264769e-02 | 1.203 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 6.264769e-02 | 1.203 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.264769e-02 | 1.203 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.264769e-02 | 1.203 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.021280e-02 | 1.220 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.021280e-02 | 1.220 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.876183e-02 | 1.231 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.744306e-02 | 1.241 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.629489e-02 | 1.250 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 5.983583e-02 | 1.223 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.844831e-02 | 1.233 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.418449e-02 | 1.193 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.418449e-02 | 1.193 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.418449e-02 | 1.193 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.459494e-02 | 1.190 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.463606e-02 | 1.190 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.752189e-02 | 1.171 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.752189e-02 | 1.171 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.750319e-02 | 1.171 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.750319e-02 | 1.171 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.416289e-02 | 1.130 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 7.485299e-02 | 1.126 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 6.752189e-02 | 1.171 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.750319e-02 | 1.171 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.617206e-02 | 1.118 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.617206e-02 | 1.118 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.175718e-02 | 1.037 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.175718e-02 | 1.037 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 9.175718e-02 | 1.037 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.175718e-02 | 1.037 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 9.175718e-02 | 1.037 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 9.175718e-02 | 1.037 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 8.216171e-02 | 1.085 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.102088e-02 | 1.091 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.102088e-02 | 1.091 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.102088e-02 | 1.091 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.102088e-02 | 1.091 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 8.689816e-02 | 1.061 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.499544e-02 | 1.071 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.499544e-02 | 1.071 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.189706e-02 | 1.087 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.189706e-02 | 1.087 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.216171e-02 | 1.085 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.216171e-02 | 1.085 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.689816e-02 | 1.061 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.689816e-02 | 1.061 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.365746e-02 | 1.077 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.018988e-02 | 1.045 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.727401e-02 | 1.059 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.560248e-02 | 1.068 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.258825e-02 | 1.033 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.388594e-02 | 1.027 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.437685e-02 | 1.025 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 9.437685e-02 | 1.025 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 9.574171e-02 | 1.019 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 9.574171e-02 | 1.019 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 9.610331e-02 | 1.017 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 9.610331e-02 | 1.017 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.610331e-02 | 1.017 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 9.762581e-02 | 1.010 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.762581e-02 | 1.010 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.867994e-02 | 1.006 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.886600e-02 | 1.005 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.894922e-02 | 1.005 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.018300e-01 | 0.992 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.018300e-01 | 0.992 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.231586e-01 | 0.910 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.116188e-01 | 0.952 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 1.090218e-01 | 0.962 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 1.090218e-01 | 0.962 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.210667e-01 | 0.917 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.210667e-01 | 0.917 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.210667e-01 | 0.917 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.043091e-01 | 0.982 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.081700e-01 | 0.966 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.178452e-01 | 0.929 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.157757e-01 | 0.936 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.231586e-01 | 0.910 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.116188e-01 | 0.952 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 1.211754e-01 | 0.917 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.090218e-01 | 0.962 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.231586e-01 | 0.910 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.043091e-01 | 0.982 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.035667e-01 | 0.985 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.032871e-01 | 0.986 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.081700e-01 | 0.966 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.211754e-01 | 0.917 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.147819e-01 | 0.940 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.043091e-01 | 0.982 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.081700e-01 | 0.966 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.193216e-01 | 0.923 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.239303e-01 | 0.907 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.239303e-01 | 0.907 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.239303e-01 | 0.907 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.239303e-01 | 0.907 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.239303e-01 | 0.907 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.239303e-01 | 0.907 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.239303e-01 | 0.907 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.239303e-01 | 0.907 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.239303e-01 | 0.907 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.262581e-01 | 0.899 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.279656e-01 | 0.893 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.285757e-01 | 0.891 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.285757e-01 | 0.891 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.285757e-01 | 0.891 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.330369e-01 | 0.876 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.829759e-01 | 0.738 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.829759e-01 | 0.738 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.829759e-01 | 0.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.829759e-01 | 0.738 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.829759e-01 | 0.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.829759e-01 | 0.738 | 0 | 0 |
| Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI) | R-HSA-9036092 | 1.829759e-01 | 0.738 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.829759e-01 | 0.738 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.829759e-01 | 0.738 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.829759e-01 | 0.738 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 2.615039e-01 | 0.583 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.615039e-01 | 0.583 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.615039e-01 | 0.583 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.615039e-01 | 0.583 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 2.615039e-01 | 0.583 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.615039e-01 | 0.583 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.615039e-01 | 0.583 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.615039e-01 | 0.583 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.583101e-01 | 0.800 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.583101e-01 | 0.800 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.583101e-01 | 0.800 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.583101e-01 | 0.800 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.941761e-01 | 0.712 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.941761e-01 | 0.712 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 1.941761e-01 | 0.712 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 1.941761e-01 | 0.712 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.941761e-01 | 0.712 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.324884e-01 | 0.478 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.324884e-01 | 0.478 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.324884e-01 | 0.478 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.324884e-01 | 0.478 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.324884e-01 | 0.478 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.459391e-01 | 0.836 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.459391e-01 | 0.836 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.309254e-01 | 0.637 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.309254e-01 | 0.637 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.699599e-01 | 0.770 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 1.699599e-01 | 0.770 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.465276e-01 | 0.834 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 1.950111e-01 | 0.710 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 2.680574e-01 | 0.572 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.680574e-01 | 0.572 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.680574e-01 | 0.572 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.966536e-01 | 0.402 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.966536e-01 | 0.402 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.411260e-01 | 0.850 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.051595e-01 | 0.515 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.051595e-01 | 0.515 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.567135e-01 | 0.805 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.054208e-01 | 0.687 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.470071e-01 | 0.833 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.264051e-01 | 0.645 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 2.743555e-01 | 0.562 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.418945e-01 | 0.466 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.418945e-01 | 0.466 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.546543e-01 | 0.342 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.546543e-01 | 0.342 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.546543e-01 | 0.342 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.479010e-01 | 0.606 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.479010e-01 | 0.606 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.698109e-01 | 0.569 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.779906e-01 | 0.423 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.779906e-01 | 0.423 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.880665e-01 | 0.726 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.435437e-01 | 0.613 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.211979e-01 | 0.655 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.018237e-01 | 0.695 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.018237e-01 | 0.695 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.622789e-01 | 0.581 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.622789e-01 | 0.581 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.562674e-01 | 0.448 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.132313e-01 | 0.384 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.132313e-01 | 0.384 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.132313e-01 | 0.384 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.132313e-01 | 0.384 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.132313e-01 | 0.384 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.132313e-01 | 0.384 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.070824e-01 | 0.295 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.070824e-01 | 0.295 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.070824e-01 | 0.295 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.713804e-01 | 0.766 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.049527e-01 | 0.516 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.474476e-01 | 0.349 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.474476e-01 | 0.349 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.474476e-01 | 0.349 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.538845e-01 | 0.595 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.103376e-01 | 0.387 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.823754e-01 | 0.418 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.808255e-01 | 0.552 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.368629e-01 | 0.360 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.805109e-01 | 0.318 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.805109e-01 | 0.318 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 4.805109e-01 | 0.318 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.805109e-01 | 0.318 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 4.805109e-01 | 0.318 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 4.805109e-01 | 0.318 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 4.805109e-01 | 0.318 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 4.805109e-01 | 0.318 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.544730e-01 | 0.256 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.544730e-01 | 0.256 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.272855e-01 | 0.369 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.629243e-01 | 0.334 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.629243e-01 | 0.334 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.629243e-01 | 0.334 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.629243e-01 | 0.334 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.629243e-01 | 0.334 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.626123e-01 | 0.441 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.494352e-01 | 0.347 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.494352e-01 | 0.347 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.123267e-01 | 0.290 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.199512e-01 | 0.377 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.713044e-01 | 0.327 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.461737e-01 | 0.350 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.461737e-01 | 0.350 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.361505e-01 | 0.360 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.133582e-01 | 0.290 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.133582e-01 | 0.290 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 5.973099e-01 | 0.224 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.973099e-01 | 0.224 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.973099e-01 | 0.224 | 0 | 0 |
| Defective CYP11A1 causes AICSR | R-HSA-5579026 | 5.973099e-01 | 0.224 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.973099e-01 | 0.224 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.683205e-01 | 0.329 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.376099e-01 | 0.270 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.145725e-01 | 0.289 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.719773e-01 | 0.243 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.719773e-01 | 0.243 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.719773e-01 | 0.243 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.719773e-01 | 0.243 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.719773e-01 | 0.243 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.719773e-01 | 0.243 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.719773e-01 | 0.243 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.305961e-01 | 0.275 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.645777e-01 | 0.248 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.688417e-01 | 0.245 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 6.360303e-01 | 0.197 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.360303e-01 | 0.197 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.360303e-01 | 0.197 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 6.360303e-01 | 0.197 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 6.360303e-01 | 0.197 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.360303e-01 | 0.197 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.360303e-01 | 0.197 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.941406e-01 | 0.226 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.059896e-01 | 0.218 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 6.272320e-01 | 0.203 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.311287e-01 | 0.200 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.359709e-01 | 0.197 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.359709e-01 | 0.197 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.517090e-01 | 0.186 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.710296e-01 | 0.173 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 6.710296e-01 | 0.173 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.710296e-01 | 0.173 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.673007e-01 | 0.176 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.706296e-01 | 0.568 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.388929e-01 | 0.857 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.054208e-01 | 0.687 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.145725e-01 | 0.289 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.145725e-01 | 0.289 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.920399e-01 | 0.535 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.581491e-01 | 0.588 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 5.302621e-01 | 0.276 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 6.059468e-01 | 0.218 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.689394e-01 | 0.245 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.382214e-01 | 0.471 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.629243e-01 | 0.334 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.410645e-01 | 0.618 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 4.972501e-01 | 0.303 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.693901e-01 | 0.174 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.208889e-01 | 0.656 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 3.562674e-01 | 0.448 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.809941e-01 | 0.318 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.934350e-01 | 0.532 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.360303e-01 | 0.197 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.819602e-01 | 0.418 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 3.061914e-01 | 0.514 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.145725e-01 | 0.289 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.208889e-01 | 0.656 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.567135e-01 | 0.805 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.006370e-01 | 0.522 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.830554e-01 | 0.234 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.101360e-01 | 0.677 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.285737e-01 | 0.368 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.499018e-01 | 0.347 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.311287e-01 | 0.200 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.473983e-01 | 0.607 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.054208e-01 | 0.687 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.199512e-01 | 0.377 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.000283e-01 | 0.301 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.713804e-01 | 0.766 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.261398e-01 | 0.203 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.508418e-01 | 0.821 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.583101e-01 | 0.800 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.699599e-01 | 0.770 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.680574e-01 | 0.572 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.779906e-01 | 0.423 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.779906e-01 | 0.423 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.132313e-01 | 0.384 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.544730e-01 | 0.256 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.272855e-01 | 0.369 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.486042e-01 | 0.458 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.608456e-01 | 0.794 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.181723e-01 | 0.286 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.500823e-01 | 0.456 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.801549e-01 | 0.553 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.628024e-01 | 0.335 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 1.941761e-01 | 0.712 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.473983e-01 | 0.607 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.418945e-01 | 0.466 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.070824e-01 | 0.295 | 0 | 0 |
| Ligand-receptor interactions | R-HSA-5632681 | 5.544730e-01 | 0.256 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.713044e-01 | 0.327 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.133582e-01 | 0.290 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 6.411356e-01 | 0.193 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.710296e-01 | 0.173 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.710296e-01 | 0.173 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.461364e-01 | 0.835 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.550003e-01 | 0.450 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.479010e-01 | 0.606 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.823754e-01 | 0.418 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.114842e-01 | 0.214 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.476714e-01 | 0.189 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.739969e-01 | 0.241 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.298940e-01 | 0.276 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 5.997490e-01 | 0.222 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.251848e-01 | 0.647 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.023134e-01 | 0.694 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.792769e-01 | 0.421 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.040867e-01 | 0.690 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.583101e-01 | 0.800 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 1.950111e-01 | 0.710 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.608456e-01 | 0.794 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 3.562674e-01 | 0.448 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.132313e-01 | 0.384 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.070824e-01 | 0.295 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.070824e-01 | 0.295 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.985069e-01 | 0.702 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 5.123267e-01 | 0.290 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.313176e-01 | 0.480 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.973099e-01 | 0.224 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.376099e-01 | 0.270 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.550353e-01 | 0.256 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.550353e-01 | 0.256 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.688417e-01 | 0.245 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.360303e-01 | 0.197 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.674131e-01 | 0.776 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 3.199861e-01 | 0.495 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.501656e-01 | 0.602 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.470071e-01 | 0.833 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.973006e-01 | 0.705 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.752976e-01 | 0.323 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.847995e-01 | 0.733 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.919499e-01 | 0.717 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.645777e-01 | 0.248 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.208889e-01 | 0.656 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.474476e-01 | 0.349 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.123267e-01 | 0.290 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.103005e-01 | 0.387 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 3.966536e-01 | 0.402 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 3.418945e-01 | 0.466 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.779906e-01 | 0.423 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.074811e-01 | 0.512 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.973099e-01 | 0.224 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.376099e-01 | 0.270 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.719773e-01 | 0.243 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.589314e-01 | 0.253 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.511582e-01 | 0.186 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.027519e-01 | 0.220 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.200056e-01 | 0.377 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.583101e-01 | 0.800 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.309254e-01 | 0.637 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.309254e-01 | 0.637 | 0 | 0 |
| Vasopressin-like receptors | R-HSA-388479 | 4.546543e-01 | 0.342 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.617798e-01 | 0.791 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.698109e-01 | 0.569 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.049115e-01 | 0.393 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.329934e-01 | 0.273 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.463707e-01 | 0.190 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.862226e-01 | 0.232 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.372945e-01 | 0.862 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.680574e-01 | 0.572 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.873713e-01 | 0.412 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.873713e-01 | 0.412 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.907910e-01 | 0.408 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.538845e-01 | 0.595 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.704250e-01 | 0.768 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 6.261398e-01 | 0.203 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.741838e-01 | 0.562 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.283461e-01 | 0.368 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.312541e-01 | 0.200 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.131188e-01 | 0.212 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 4.596408e-01 | 0.338 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.550353e-01 | 0.256 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.722086e-01 | 0.172 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.919538e-01 | 0.407 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.960052e-01 | 0.708 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.870121e-01 | 0.542 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.909306e-01 | 0.408 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.829759e-01 | 0.738 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.324884e-01 | 0.478 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.324884e-01 | 0.478 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.680574e-01 | 0.572 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 3.966536e-01 | 0.402 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.743555e-01 | 0.562 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.546543e-01 | 0.342 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 1.464789e-01 | 0.834 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 4.132313e-01 | 0.384 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.070824e-01 | 0.295 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.070824e-01 | 0.295 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.410645e-01 | 0.618 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.410645e-01 | 0.618 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.474476e-01 | 0.349 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.474476e-01 | 0.349 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.911772e-01 | 0.536 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.103376e-01 | 0.387 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.544730e-01 | 0.256 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.544730e-01 | 0.256 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.970390e-01 | 0.401 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.055959e-01 | 0.515 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.981035e-01 | 0.400 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.133582e-01 | 0.290 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.472752e-01 | 0.349 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.376099e-01 | 0.270 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.719773e-01 | 0.243 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.611549e-01 | 0.251 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.748424e-01 | 0.240 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.997490e-01 | 0.222 | 0 | 0 |
| Electron transport from NADPH to Ferredoxin | R-HSA-2395516 | 6.360303e-01 | 0.197 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.191256e-01 | 0.208 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.710296e-01 | 0.173 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.710296e-01 | 0.173 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.710296e-01 | 0.173 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.710296e-01 | 0.173 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.510013e-01 | 0.346 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.510808e-01 | 0.186 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.708273e-01 | 0.567 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.719742e-01 | 0.765 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.780362e-01 | 0.321 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.304291e-01 | 0.637 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.648273e-01 | 0.783 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.785060e-01 | 0.748 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.006577e-01 | 0.300 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.823912e-01 | 0.739 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.496680e-01 | 0.260 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.460238e-01 | 0.609 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.418945e-01 | 0.466 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 2.251848e-01 | 0.647 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.779906e-01 | 0.423 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.779906e-01 | 0.423 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.368629e-01 | 0.360 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.488226e-01 | 0.457 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.593705e-01 | 0.444 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.459391e-01 | 0.836 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.289409e-01 | 0.483 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.878333e-01 | 0.231 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.546543e-01 | 0.342 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.673610e-01 | 0.776 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.805109e-01 | 0.318 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.544730e-01 | 0.256 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.544730e-01 | 0.256 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.376099e-01 | 0.270 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.039321e-01 | 0.219 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.866949e-01 | 0.543 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.383372e-01 | 0.471 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.629243e-01 | 0.334 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 6.132380e-01 | 0.212 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.329628e-01 | 0.199 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.473983e-01 | 0.607 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 3.519150e-01 | 0.454 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.304331e-01 | 0.366 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.449230e-01 | 0.190 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.415111e-01 | 0.266 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.204978e-01 | 0.657 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.271964e-01 | 0.369 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.008611e-01 | 0.697 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.108885e-01 | 0.386 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.038715e-01 | 0.691 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.724171e-01 | 0.429 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.756242e-01 | 0.560 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.059896e-01 | 0.218 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.069222e-01 | 0.513 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.743555e-01 | 0.562 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.546543e-01 | 0.342 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.779906e-01 | 0.423 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.562674e-01 | 0.448 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.544730e-01 | 0.256 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.428294e-01 | 0.265 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 5.151199e-01 | 0.288 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 5.839572e-01 | 0.234 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.360303e-01 | 0.197 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.360303e-01 | 0.197 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.511582e-01 | 0.186 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.710296e-01 | 0.173 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.710296e-01 | 0.173 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.710296e-01 | 0.173 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.710296e-01 | 0.173 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.399826e-01 | 0.469 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 4.928419e-01 | 0.307 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.129084e-01 | 0.213 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.719501e-01 | 0.566 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.140022e-01 | 0.289 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.127581e-01 | 0.384 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.712202e-01 | 0.173 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.511582e-01 | 0.186 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.617798e-01 | 0.791 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.459391e-01 | 0.836 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.309254e-01 | 0.637 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.132313e-01 | 0.384 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.121250e-01 | 0.385 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.115740e-01 | 0.386 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.683205e-01 | 0.329 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.719773e-01 | 0.243 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.471917e-01 | 0.350 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.006370e-01 | 0.522 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 3.834383e-01 | 0.416 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.880665e-01 | 0.726 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.324884e-01 | 0.478 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 2.680574e-01 | 0.572 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.208889e-01 | 0.656 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.546543e-01 | 0.342 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.493005e-01 | 0.826 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.070824e-01 | 0.295 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.070824e-01 | 0.295 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.040867e-01 | 0.690 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.706296e-01 | 0.568 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.201415e-01 | 0.495 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.544730e-01 | 0.256 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.123267e-01 | 0.290 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.713044e-01 | 0.327 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 5.973099e-01 | 0.224 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.166925e-01 | 0.287 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 5.463546e-01 | 0.263 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.360303e-01 | 0.197 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.360303e-01 | 0.197 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 6.710296e-01 | 0.173 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.986783e-01 | 0.702 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.943706e-01 | 0.531 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.979825e-01 | 0.223 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.574686e-01 | 0.447 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.884447e-01 | 0.311 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.724370e-01 | 0.172 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.108885e-01 | 0.386 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.997490e-01 | 0.222 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.724370e-01 | 0.172 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 2.706296e-01 | 0.568 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.127240e-01 | 0.672 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.911772e-01 | 0.536 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.751833e-01 | 0.323 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.329934e-01 | 0.273 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.494352e-01 | 0.347 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 2.698109e-01 | 0.569 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.397862e-01 | 0.469 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.069222e-01 | 0.513 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.805109e-01 | 0.318 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.544730e-01 | 0.256 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 5.973099e-01 | 0.224 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.973099e-01 | 0.224 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.719773e-01 | 0.243 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.997490e-01 | 0.222 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.360303e-01 | 0.197 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.710296e-01 | 0.173 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.059896e-01 | 0.218 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.271964e-01 | 0.369 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.658759e-01 | 0.177 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.285737e-01 | 0.368 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.511582e-01 | 0.186 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.560043e-01 | 0.183 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.411260e-01 | 0.850 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.428294e-01 | 0.265 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.748424e-01 | 0.240 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.997490e-01 | 0.222 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.710296e-01 | 0.173 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.834383e-01 | 0.416 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.360303e-01 | 0.197 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 6.261398e-01 | 0.203 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.487879e-01 | 0.188 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.710296e-01 | 0.173 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 4.494352e-01 | 0.347 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.997490e-01 | 0.222 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.261398e-01 | 0.203 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.311287e-01 | 0.200 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 6.658759e-01 | 0.177 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.595157e-01 | 0.444 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.428294e-01 | 0.265 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 6.050817e-01 | 0.218 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.261398e-01 | 0.203 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 5.571838e-01 | 0.254 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.779906e-01 | 0.423 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.710296e-01 | 0.173 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.343953e-01 | 0.362 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.608456e-01 | 0.794 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.023134e-01 | 0.694 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.476714e-01 | 0.189 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.103376e-01 | 0.387 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.376099e-01 | 0.270 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.744677e-01 | 0.171 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.748244e-01 | 0.171 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.748244e-01 | 0.171 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.748244e-01 | 0.171 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.748244e-01 | 0.171 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.748244e-01 | 0.171 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.748244e-01 | 0.171 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.758483e-01 | 0.170 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.818588e-01 | 0.166 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.818588e-01 | 0.166 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.823863e-01 | 0.166 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 6.829745e-01 | 0.166 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 6.829745e-01 | 0.166 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 6.829745e-01 | 0.166 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 6.829745e-01 | 0.166 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 6.829745e-01 | 0.166 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.831698e-01 | 0.165 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.850116e-01 | 0.164 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.850116e-01 | 0.164 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.850116e-01 | 0.164 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.861185e-01 | 0.164 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 6.861185e-01 | 0.164 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.861185e-01 | 0.164 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 6.961896e-01 | 0.157 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.971668e-01 | 0.157 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.971668e-01 | 0.157 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.971668e-01 | 0.157 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.971668e-01 | 0.157 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.983152e-01 | 0.156 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.017803e-01 | 0.154 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.026653e-01 | 0.153 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.026653e-01 | 0.153 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.026653e-01 | 0.153 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.026653e-01 | 0.153 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.026653e-01 | 0.153 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.026653e-01 | 0.153 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.026653e-01 | 0.153 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.026653e-01 | 0.153 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.026653e-01 | 0.153 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.026653e-01 | 0.153 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.026653e-01 | 0.153 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.026653e-01 | 0.153 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.026653e-01 | 0.153 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.026653e-01 | 0.153 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.026653e-01 | 0.153 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.034783e-01 | 0.153 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.038512e-01 | 0.153 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.038512e-01 | 0.153 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.041278e-01 | 0.152 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.041278e-01 | 0.152 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.090317e-01 | 0.149 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.102028e-01 | 0.149 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.136617e-01 | 0.147 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.136617e-01 | 0.147 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.182212e-01 | 0.144 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.182212e-01 | 0.144 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.182212e-01 | 0.144 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.210994e-01 | 0.142 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 7.211903e-01 | 0.142 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.213359e-01 | 0.142 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.213359e-01 | 0.142 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.213359e-01 | 0.142 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.213359e-01 | 0.142 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.213359e-01 | 0.142 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.214984e-01 | 0.142 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.214984e-01 | 0.142 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.214984e-01 | 0.142 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.236633e-01 | 0.140 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.236906e-01 | 0.140 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.236906e-01 | 0.140 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.254525e-01 | 0.139 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.284275e-01 | 0.138 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.312604e-01 | 0.136 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.312604e-01 | 0.136 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.312604e-01 | 0.136 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.312604e-01 | 0.136 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.312604e-01 | 0.136 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.312604e-01 | 0.136 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.332379e-01 | 0.135 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.332379e-01 | 0.135 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.362140e-01 | 0.133 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.367219e-01 | 0.133 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.367219e-01 | 0.133 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.367219e-01 | 0.133 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.377536e-01 | 0.132 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.380287e-01 | 0.132 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.380287e-01 | 0.132 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.380287e-01 | 0.132 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.380287e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.425896e-01 | 0.129 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 7.431420e-01 | 0.129 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.489842e-01 | 0.126 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.492983e-01 | 0.125 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.516717e-01 | 0.124 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.531396e-01 | 0.123 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.533950e-01 | 0.123 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.533950e-01 | 0.123 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.533950e-01 | 0.123 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.533950e-01 | 0.123 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.533950e-01 | 0.123 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.566343e-01 | 0.121 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.566343e-01 | 0.121 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.571070e-01 | 0.121 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.571070e-01 | 0.121 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.571070e-01 | 0.121 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.571070e-01 | 0.121 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.571070e-01 | 0.121 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.571070e-01 | 0.121 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.571070e-01 | 0.121 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.571070e-01 | 0.121 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.571070e-01 | 0.121 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.614229e-01 | 0.118 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.682764e-01 | 0.114 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.682764e-01 | 0.114 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 7.692874e-01 | 0.114 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.700760e-01 | 0.113 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.700760e-01 | 0.113 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.700760e-01 | 0.113 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.730997e-01 | 0.112 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.730997e-01 | 0.112 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.740860e-01 | 0.111 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.804691e-01 | 0.108 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.804691e-01 | 0.108 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.804691e-01 | 0.108 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.804691e-01 | 0.108 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.804691e-01 | 0.108 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.804691e-01 | 0.108 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.817865e-01 | 0.107 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.817865e-01 | 0.107 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.824166e-01 | 0.107 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.824166e-01 | 0.107 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.824166e-01 | 0.107 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 7.824166e-01 | 0.107 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.824166e-01 | 0.107 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 7.824166e-01 | 0.107 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 7.824166e-01 | 0.107 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.859865e-01 | 0.105 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.859865e-01 | 0.105 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.874864e-01 | 0.104 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.904335e-01 | 0.102 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.904335e-01 | 0.102 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.904335e-01 | 0.102 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.904335e-01 | 0.102 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.958361e-01 | 0.099 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.982773e-01 | 0.098 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.991546e-01 | 0.097 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.015855e-01 | 0.096 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.015855e-01 | 0.096 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.015855e-01 | 0.096 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.015855e-01 | 0.096 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.015855e-01 | 0.096 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.015855e-01 | 0.096 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.015855e-01 | 0.096 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.015855e-01 | 0.096 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.039127e-01 | 0.095 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.055020e-01 | 0.094 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.057277e-01 | 0.094 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.057277e-01 | 0.094 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.057277e-01 | 0.094 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.057277e-01 | 0.094 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.077789e-01 | 0.093 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.077789e-01 | 0.093 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.085566e-01 | 0.092 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.085566e-01 | 0.092 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.085566e-01 | 0.092 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.160666e-01 | 0.088 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.169274e-01 | 0.088 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.182013e-01 | 0.087 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.195957e-01 | 0.086 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.200200e-01 | 0.086 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.200200e-01 | 0.086 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.206718e-01 | 0.086 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.206718e-01 | 0.086 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.206718e-01 | 0.086 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.206718e-01 | 0.086 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.206718e-01 | 0.086 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.206718e-01 | 0.086 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.206718e-01 | 0.086 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.206718e-01 | 0.086 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.206718e-01 | 0.086 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.206718e-01 | 0.086 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.222761e-01 | 0.085 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 8.249867e-01 | 0.084 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.257290e-01 | 0.083 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.264628e-01 | 0.083 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.277654e-01 | 0.082 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.277654e-01 | 0.082 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.307568e-01 | 0.081 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.319938e-01 | 0.080 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 8.319938e-01 | 0.080 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.333615e-01 | 0.079 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.333615e-01 | 0.079 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.333615e-01 | 0.079 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.341199e-01 | 0.079 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 8.341902e-01 | 0.079 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.341902e-01 | 0.079 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.348929e-01 | 0.078 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.348929e-01 | 0.078 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.348929e-01 | 0.078 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.363667e-01 | 0.078 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.374674e-01 | 0.077 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.379231e-01 | 0.077 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.379231e-01 | 0.077 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.379231e-01 | 0.077 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.379231e-01 | 0.077 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.379231e-01 | 0.077 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.379231e-01 | 0.077 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 8.379231e-01 | 0.077 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.379231e-01 | 0.077 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.407887e-01 | 0.075 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.423180e-01 | 0.075 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.423180e-01 | 0.075 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.427585e-01 | 0.074 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.428598e-01 | 0.074 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.458029e-01 | 0.073 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.458029e-01 | 0.073 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.458029e-01 | 0.073 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 8.458029e-01 | 0.073 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.458029e-01 | 0.073 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.497627e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.501198e-01 | 0.071 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.502683e-01 | 0.070 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 8.505314e-01 | 0.070 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.512165e-01 | 0.070 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.535158e-01 | 0.069 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.535158e-01 | 0.069 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.535158e-01 | 0.069 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.535158e-01 | 0.069 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.535158e-01 | 0.069 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.535158e-01 | 0.069 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.535158e-01 | 0.069 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.535158e-01 | 0.069 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.535158e-01 | 0.069 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.535158e-01 | 0.069 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.535158e-01 | 0.069 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.535158e-01 | 0.069 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.535158e-01 | 0.069 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.535158e-01 | 0.069 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.539267e-01 | 0.069 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.539267e-01 | 0.069 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.547569e-01 | 0.068 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.573938e-01 | 0.067 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.592006e-01 | 0.066 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.601646e-01 | 0.065 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.622628e-01 | 0.064 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.622628e-01 | 0.064 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.632737e-01 | 0.064 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.647761e-01 | 0.063 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.676092e-01 | 0.062 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.676092e-01 | 0.062 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.676092e-01 | 0.062 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.676092e-01 | 0.062 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.676092e-01 | 0.062 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.676092e-01 | 0.062 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.676092e-01 | 0.062 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.676092e-01 | 0.062 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.676092e-01 | 0.062 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.676092e-01 | 0.062 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.676092e-01 | 0.062 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.676092e-01 | 0.062 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.681827e-01 | 0.061 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.681827e-01 | 0.061 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.681827e-01 | 0.061 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.681827e-01 | 0.061 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.681827e-01 | 0.061 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.681827e-01 | 0.061 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.715336e-01 | 0.060 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.740940e-01 | 0.058 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.782166e-01 | 0.056 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.782232e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.788031e-01 | 0.056 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.788031e-01 | 0.056 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.790287e-01 | 0.056 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.800350e-01 | 0.056 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.800350e-01 | 0.056 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.803475e-01 | 0.055 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.803475e-01 | 0.055 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.803475e-01 | 0.055 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.803475e-01 | 0.055 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.803475e-01 | 0.055 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.810254e-01 | 0.055 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.810254e-01 | 0.055 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.830068e-01 | 0.054 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.839442e-01 | 0.054 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.839442e-01 | 0.054 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.862984e-01 | 0.052 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.875407e-01 | 0.052 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.876283e-01 | 0.052 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 8.880320e-01 | 0.052 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.887429e-01 | 0.051 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.905282e-01 | 0.050 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.908868e-01 | 0.050 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.918607e-01 | 0.050 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 8.918607e-01 | 0.050 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.918607e-01 | 0.050 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.918607e-01 | 0.050 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.918607e-01 | 0.050 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.918607e-01 | 0.050 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.918607e-01 | 0.050 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.918607e-01 | 0.050 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.931838e-01 | 0.049 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.939138e-01 | 0.049 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.955486e-01 | 0.048 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.961989e-01 | 0.048 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.961989e-01 | 0.048 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.962736e-01 | 0.048 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.971904e-01 | 0.047 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.972426e-01 | 0.047 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.995140e-01 | 0.046 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 8.998931e-01 | 0.046 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 9.022668e-01 | 0.045 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.022668e-01 | 0.045 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.022668e-01 | 0.045 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.022668e-01 | 0.045 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.022668e-01 | 0.045 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.022668e-01 | 0.045 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.022668e-01 | 0.045 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 9.022668e-01 | 0.045 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.022668e-01 | 0.045 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.042328e-01 | 0.044 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.042328e-01 | 0.044 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.042328e-01 | 0.044 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.058638e-01 | 0.043 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.058638e-01 | 0.043 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.065710e-01 | 0.043 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.073695e-01 | 0.042 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.092341e-01 | 0.041 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.092341e-01 | 0.041 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.116720e-01 | 0.040 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.116720e-01 | 0.040 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.116720e-01 | 0.040 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.116720e-01 | 0.040 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.116720e-01 | 0.040 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.116720e-01 | 0.040 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.116720e-01 | 0.040 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.116720e-01 | 0.040 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.116720e-01 | 0.040 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.116824e-01 | 0.040 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.116824e-01 | 0.040 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.116824e-01 | 0.040 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.116890e-01 | 0.040 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.120784e-01 | 0.040 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.154481e-01 | 0.038 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.155306e-01 | 0.038 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.160888e-01 | 0.038 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.184015e-01 | 0.037 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.185858e-01 | 0.037 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.185858e-01 | 0.037 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.185858e-01 | 0.037 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.188319e-01 | 0.037 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.188319e-01 | 0.037 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.188319e-01 | 0.037 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 9.201727e-01 | 0.036 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.201727e-01 | 0.036 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.201727e-01 | 0.036 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.201727e-01 | 0.036 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.201727e-01 | 0.036 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.212722e-01 | 0.036 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.223841e-01 | 0.035 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.224954e-01 | 0.035 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.226131e-01 | 0.035 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.249790e-01 | 0.034 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.249790e-01 | 0.034 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.266355e-01 | 0.033 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.267270e-01 | 0.033 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.278557e-01 | 0.033 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.278557e-01 | 0.033 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.278557e-01 | 0.033 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.278557e-01 | 0.033 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.278557e-01 | 0.033 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 9.278557e-01 | 0.033 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.278557e-01 | 0.033 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.290705e-01 | 0.032 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.304428e-01 | 0.031 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 9.308962e-01 | 0.031 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 9.308962e-01 | 0.031 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.308962e-01 | 0.031 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.318329e-01 | 0.031 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.319011e-01 | 0.031 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.319181e-01 | 0.031 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.319181e-01 | 0.031 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.347997e-01 | 0.029 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.347997e-01 | 0.029 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.347997e-01 | 0.029 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.363699e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.363699e-01 | 0.029 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.363699e-01 | 0.029 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.373066e-01 | 0.028 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.410745e-01 | 0.026 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.410745e-01 | 0.026 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.410745e-01 | 0.026 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.410756e-01 | 0.026 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.410756e-01 | 0.026 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.410756e-01 | 0.026 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.410756e-01 | 0.026 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.410756e-01 | 0.026 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.410756e-01 | 0.026 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.417340e-01 | 0.026 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.417340e-01 | 0.026 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.445333e-01 | 0.025 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 9.452468e-01 | 0.024 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.461069e-01 | 0.024 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.467478e-01 | 0.024 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.467478e-01 | 0.024 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.467478e-01 | 0.024 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.467478e-01 | 0.024 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.467478e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.467478e-01 | 0.024 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.467478e-01 | 0.024 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.467478e-01 | 0.024 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.467478e-01 | 0.024 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.471353e-01 | 0.024 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.491430e-01 | 0.023 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.497040e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.503678e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.504261e-01 | 0.022 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.504261e-01 | 0.022 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.504261e-01 | 0.022 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.504261e-01 | 0.022 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.504261e-01 | 0.022 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.504261e-01 | 0.022 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.518743e-01 | 0.021 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.518743e-01 | 0.021 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.518743e-01 | 0.021 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.518743e-01 | 0.021 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.518743e-01 | 0.021 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.518743e-01 | 0.021 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.521682e-01 | 0.021 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.532247e-01 | 0.021 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.543175e-01 | 0.020 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.544134e-01 | 0.020 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.544134e-01 | 0.020 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.544134e-01 | 0.020 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.565076e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.565076e-01 | 0.019 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.565076e-01 | 0.019 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.565076e-01 | 0.019 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.566646e-01 | 0.019 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.577977e-01 | 0.019 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.577977e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.580929e-01 | 0.019 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.580929e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.580929e-01 | 0.019 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.580929e-01 | 0.019 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.580929e-01 | 0.019 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.580929e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.580929e-01 | 0.019 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.584971e-01 | 0.018 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.602772e-01 | 0.018 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.606950e-01 | 0.017 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.606950e-01 | 0.017 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.606950e-01 | 0.017 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.606950e-01 | 0.017 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.606950e-01 | 0.017 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.606950e-01 | 0.017 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.606950e-01 | 0.017 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.606950e-01 | 0.017 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.613085e-01 | 0.017 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 9.614867e-01 | 0.017 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.614867e-01 | 0.017 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.622828e-01 | 0.017 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.622828e-01 | 0.017 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.641812e-01 | 0.016 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.644795e-01 | 0.016 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.644795e-01 | 0.016 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.644795e-01 | 0.016 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.644795e-01 | 0.016 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.644795e-01 | 0.016 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.644795e-01 | 0.016 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.644795e-01 | 0.016 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.644795e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.646158e-01 | 0.016 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.646158e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.646158e-01 | 0.016 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.649073e-01 | 0.016 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.652276e-01 | 0.015 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.674996e-01 | 0.014 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.674996e-01 | 0.014 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.674996e-01 | 0.014 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.675852e-01 | 0.014 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.677398e-01 | 0.014 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.677398e-01 | 0.014 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.678998e-01 | 0.014 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.678998e-01 | 0.014 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.685254e-01 | 0.014 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.701563e-01 | 0.013 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.701563e-01 | 0.013 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.701563e-01 | 0.013 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.701563e-01 | 0.013 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.701563e-01 | 0.013 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.706130e-01 | 0.013 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.709909e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.709909e-01 | 0.013 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.709909e-01 | 0.013 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.709909e-01 | 0.013 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.711458e-01 | 0.013 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.721779e-01 | 0.012 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.726030e-01 | 0.012 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.733632e-01 | 0.012 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.737846e-01 | 0.012 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.737846e-01 | 0.012 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.737846e-01 | 0.012 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.743924e-01 | 0.011 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.748554e-01 | 0.011 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.748554e-01 | 0.011 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.754195e-01 | 0.011 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.763093e-01 | 0.010 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.763093e-01 | 0.010 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.763423e-01 | 0.010 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.763423e-01 | 0.010 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.764882e-01 | 0.010 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.764882e-01 | 0.010 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.769282e-01 | 0.010 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 9.769282e-01 | 0.010 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.769282e-01 | 0.010 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.773601e-01 | 0.010 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.785910e-01 | 0.009 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.785910e-01 | 0.009 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.787589e-01 | 0.009 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.790833e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.795772e-01 | 0.009 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.801636e-01 | 0.009 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.805890e-01 | 0.009 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.806531e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.806531e-01 | 0.008 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.808068e-01 | 0.008 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.825167e-01 | 0.008 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.825167e-01 | 0.008 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.829291e-01 | 0.007 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.830472e-01 | 0.007 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.836835e-01 | 0.007 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.842009e-01 | 0.007 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.842009e-01 | 0.007 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.842009e-01 | 0.007 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.842009e-01 | 0.007 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.842009e-01 | 0.007 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.842009e-01 | 0.007 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.842009e-01 | 0.007 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.850453e-01 | 0.007 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.850755e-01 | 0.007 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.852669e-01 | 0.006 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.857229e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.857229e-01 | 0.006 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.857229e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.862100e-01 | 0.006 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.862100e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.862963e-01 | 0.006 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.865368e-01 | 0.006 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.866177e-01 | 0.006 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.868157e-01 | 0.006 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.870984e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.870984e-01 | 0.006 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.870984e-01 | 0.006 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.870984e-01 | 0.006 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.880226e-01 | 0.005 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.880270e-01 | 0.005 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.883415e-01 | 0.005 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.883415e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.883415e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.883415e-01 | 0.005 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.884999e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.884999e-01 | 0.005 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.889240e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.894648e-01 | 0.005 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.894648e-01 | 0.005 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.894680e-01 | 0.005 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.895737e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.897194e-01 | 0.004 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.898462e-01 | 0.004 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.902377e-01 | 0.004 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.902855e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.904800e-01 | 0.004 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.904800e-01 | 0.004 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.911715e-01 | 0.004 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.912545e-01 | 0.004 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.913974e-01 | 0.004 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.913974e-01 | 0.004 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.913974e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.914624e-01 | 0.004 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.916272e-01 | 0.004 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.918865e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.918865e-01 | 0.004 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.921244e-01 | 0.003 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.921244e-01 | 0.003 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.922278e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.924746e-01 | 0.003 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.926046e-01 | 0.003 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.926046e-01 | 0.003 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.926046e-01 | 0.003 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.926046e-01 | 0.003 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.929756e-01 | 0.003 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.929756e-01 | 0.003 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.929756e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.929756e-01 | 0.003 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.930516e-01 | 0.003 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.930516e-01 | 0.003 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.931601e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.932331e-01 | 0.003 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.933027e-01 | 0.003 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.936526e-01 | 0.003 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.936526e-01 | 0.003 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.940035e-01 | 0.003 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.940472e-01 | 0.003 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.942644e-01 | 0.002 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.943372e-01 | 0.002 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.945689e-01 | 0.002 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.948173e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.948173e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.948173e-01 | 0.002 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.948210e-01 | 0.002 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.949842e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.952312e-01 | 0.002 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.952312e-01 | 0.002 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.953169e-01 | 0.002 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.953169e-01 | 0.002 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.953169e-01 | 0.002 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.953169e-01 | 0.002 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.956526e-01 | 0.002 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 9.956700e-01 | 0.002 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.956700e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.956700e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.956700e-01 | 0.002 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.957684e-01 | 0.002 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.957684e-01 | 0.002 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.959016e-01 | 0.002 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.965258e-01 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.966934e-01 | 0.001 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.967995e-01 | 0.001 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.968782e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.968782e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.969785e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.971945e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.972066e-01 | 0.001 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.972210e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.972393e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.974512e-01 | 0.001 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.974512e-01 | 0.001 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.974512e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.974512e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.974512e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.974512e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.976276e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.978825e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.983584e-01 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.983983e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.983983e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.983983e-01 | 0.001 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.985229e-01 | 0.001 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.985378e-01 | 0.001 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.986168e-01 | 0.001 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.986447e-01 | 0.001 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.986979e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.987329e-01 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.987329e-01 | 0.001 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.987405e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.987819e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.988372e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.988410e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.988678e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.989127e-01 | 0.000 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.989771e-01 | 0.000 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.990758e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990758e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.990956e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.992455e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.992975e-01 | 0.000 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.993003e-01 | 0.000 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.993003e-01 | 0.000 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.993183e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.993306e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.993306e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.993609e-01 | 0.000 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.993671e-01 | 0.000 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.993898e-01 | 0.000 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.994157e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.994672e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994973e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.994973e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.995039e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.995142e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.995449e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.995458e-01 | 0.000 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.995571e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.995931e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.996019e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.996320e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.996651e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.996909e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.997214e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997266e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.997462e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.997462e-01 | 0.000 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.997530e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.997769e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.997769e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998251e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.998355e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.998407e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.998476e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998514e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.998549e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.998770e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.998787e-01 | 0.000 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.998797e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.998829e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.999010e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999056e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999276e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.999432e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999432e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999483e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999683e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999708e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999736e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999773e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999916e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999922e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999934e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999951e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999951e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999952e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999959e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999960e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999962e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999973e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999975e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999979e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999979e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999982e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999983e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999984e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999984e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.999987e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999993e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.067931e-09 | 8.971 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 6.444621e-08 | 7.191 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.655755e-08 | 7.116 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.629727e-06 | 5.440 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 8.962721e-06 | 5.048 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 8.962721e-06 | 5.048 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.404307e-06 | 5.027 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.800156e-05 | 4.553 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.202648e-05 | 4.376 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.202648e-05 | 4.376 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.568689e-05 | 4.340 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 4.908238e-05 | 4.309 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.153313e-05 | 4.211 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.254400e-04 | 3.647 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.339604e-04 | 3.631 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.482686e-04 | 3.605 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.573226e-04 | 3.590 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.020913e-04 | 3.520 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.089015e-04 | 3.510 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.846597e-04 | 3.415 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.483826e-04 | 3.348 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.705800e-04 | 3.327 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.339133e-04 | 3.273 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 5.816965e-04 | 3.235 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.380032e-04 | 3.077 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.206229e-04 | 3.086 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.328137e-04 | 3.030 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 9.116548e-04 | 3.040 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.189367e-04 | 3.037 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.684469e-04 | 3.014 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.144595e-03 | 2.941 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.358226e-03 | 2.867 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.330551e-03 | 2.876 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.829551e-03 | 2.738 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.051817e-03 | 2.688 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.000074e-03 | 2.699 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.142274e-03 | 2.669 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.888292e-03 | 2.539 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.223401e-03 | 2.492 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 3.736630e-03 | 2.428 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.801143e-03 | 2.420 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.490250e-03 | 2.348 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.567434e-03 | 2.340 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.763283e-03 | 2.322 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.763283e-03 | 2.322 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.001674e-03 | 2.222 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.242487e-03 | 2.205 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.923164e-03 | 2.160 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 7.517606e-03 | 2.124 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 7.517606e-03 | 2.124 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.947446e-03 | 2.158 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.635516e-03 | 2.117 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 8.094497e-03 | 2.092 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 8.122109e-03 | 2.090 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.713035e-03 | 2.060 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 9.981158e-03 | 2.001 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.028544e-02 | 1.988 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.035083e-02 | 1.985 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.035083e-02 | 1.985 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.073877e-02 | 1.969 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.215507e-02 | 1.915 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.193002e-02 | 1.923 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.177650e-02 | 1.929 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.179939e-02 | 1.928 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.193002e-02 | 1.923 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.284020e-02 | 1.891 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.284020e-02 | 1.891 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.276839e-02 | 1.894 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.286218e-02 | 1.891 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.295096e-02 | 1.888 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.303097e-02 | 1.885 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.377026e-02 | 1.861 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.478835e-02 | 1.830 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.525783e-02 | 1.817 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.555029e-02 | 1.808 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.655440e-02 | 1.781 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.628354e-02 | 1.788 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.581728e-02 | 1.801 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.589674e-02 | 1.799 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.662473e-02 | 1.779 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.681714e-02 | 1.774 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.700575e-02 | 1.769 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.974162e-02 | 1.705 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.974162e-02 | 1.705 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.974162e-02 | 1.705 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.974162e-02 | 1.705 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.974162e-02 | 1.705 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.974162e-02 | 1.705 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.926358e-02 | 1.715 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.925567e-02 | 1.715 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.925567e-02 | 1.715 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.844919e-02 | 1.734 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.871870e-02 | 1.728 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.058408e-02 | 1.686 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.058408e-02 | 1.686 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.328103e-02 | 1.633 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.328103e-02 | 1.633 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.180591e-02 | 1.661 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.282438e-02 | 1.642 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.282438e-02 | 1.642 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.496208e-02 | 1.603 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.518904e-02 | 1.599 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 2.719730e-02 | 1.565 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.772122e-02 | 1.557 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.604727e-02 | 1.584 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.782184e-02 | 1.556 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.664335e-02 | 1.574 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.992586e-02 | 1.524 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.016696e-02 | 1.520 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.035887e-02 | 1.518 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.973244e-02 | 1.527 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.035887e-02 | 1.518 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.960592e-02 | 1.529 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.955630e-02 | 1.529 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.960592e-02 | 1.529 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.028813e-02 | 1.519 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.955630e-02 | 1.529 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.141291e-02 | 1.503 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.226735e-02 | 1.491 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.265417e-02 | 1.486 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.373635e-02 | 1.472 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.373635e-02 | 1.472 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 3.374615e-02 | 1.472 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.724308e-02 | 1.429 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.724308e-02 | 1.429 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.543589e-02 | 1.451 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.723833e-02 | 1.429 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.724308e-02 | 1.429 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.641265e-02 | 1.439 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.739807e-02 | 1.427 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.860254e-02 | 1.413 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.880092e-02 | 1.411 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 3.999032e-02 | 1.398 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.144027e-02 | 1.383 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.438660e-02 | 1.353 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.556659e-02 | 1.341 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.530005e-02 | 1.257 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.210213e-02 | 1.283 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.491181e-02 | 1.260 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 5.473173e-02 | 1.262 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.406198e-02 | 1.267 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.498668e-02 | 1.260 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.575254e-02 | 1.254 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.254015e-02 | 1.280 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 5.623904e-02 | 1.250 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.877664e-02 | 1.163 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.877664e-02 | 1.163 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.877664e-02 | 1.163 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.877664e-02 | 1.163 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.297719e-02 | 1.137 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 7.297719e-02 | 1.137 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 6.465603e-02 | 1.189 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.204012e-02 | 1.142 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.653759e-02 | 1.177 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.653759e-02 | 1.177 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 6.090086e-02 | 1.215 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.825833e-02 | 1.166 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 6.793026e-02 | 1.168 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.130583e-02 | 1.212 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.937555e-02 | 1.226 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.017413e-02 | 1.154 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.017413e-02 | 1.154 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 6.855506e-02 | 1.164 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.853297e-02 | 1.233 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 6.116736e-02 | 1.213 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.904245e-02 | 1.229 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.297719e-02 | 1.137 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 7.297719e-02 | 1.137 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.116736e-02 | 1.213 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.853297e-02 | 1.233 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.073511e-02 | 1.150 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.090086e-02 | 1.215 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.507930e-02 | 1.187 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.204012e-02 | 1.142 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.516912e-02 | 1.124 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.516912e-02 | 1.124 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.516912e-02 | 1.124 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.613823e-02 | 1.118 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.666960e-02 | 1.115 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.670379e-02 | 1.115 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.863971e-02 | 1.104 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.928033e-02 | 1.101 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.976748e-02 | 1.098 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.282738e-02 | 1.032 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.282738e-02 | 1.032 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 9.282738e-02 | 1.032 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 9.399497e-02 | 1.027 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 9.399497e-02 | 1.027 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 9.399497e-02 | 1.027 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.229115e-02 | 1.085 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.346704e-02 | 1.029 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.608952e-02 | 1.065 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.404238e-02 | 1.076 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.404238e-02 | 1.076 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.585083e-02 | 1.066 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.772969e-02 | 1.057 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 9.399497e-02 | 1.027 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.805937e-02 | 1.055 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.798786e-02 | 1.056 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.118440e-02 | 1.040 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.774950e-02 | 1.057 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.297413e-02 | 1.081 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.388860e-02 | 1.027 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.449951e-02 | 1.025 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.003896e-01 | 0.998 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.003896e-01 | 0.998 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.003896e-01 | 0.998 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 1.011413e-01 | 0.995 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.011413e-01 | 0.995 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.022073e-01 | 0.991 | 0 | 0 |
| MGMT-mediated DNA damage reversal | R-HSA-5657655 | 1.920583e-01 | 0.717 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.920583e-01 | 0.717 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.920583e-01 | 0.717 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.920583e-01 | 0.717 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.920583e-01 | 0.717 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.920583e-01 | 0.717 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.351356e-01 | 0.869 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.351356e-01 | 0.869 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.351356e-01 | 0.869 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 1.351356e-01 | 0.869 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 1.351356e-01 | 0.869 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.351356e-01 | 0.869 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 2.737842e-01 | 0.563 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 2.737842e-01 | 0.563 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.737842e-01 | 0.563 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.737842e-01 | 0.563 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 2.737842e-01 | 0.563 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.737842e-01 | 0.563 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 2.737842e-01 | 0.563 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 1.720583e-01 | 0.764 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.720583e-01 | 0.764 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.381347e-01 | 0.860 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.381347e-01 | 0.860 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.103625e-01 | 0.677 | 0 | 0 |
| Defective ALG9 causes CDG-1l | R-HSA-4720454 | 3.472476e-01 | 0.459 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 3.472476e-01 | 0.459 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.472476e-01 | 0.459 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 3.472476e-01 | 0.459 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.472476e-01 | 0.459 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.472476e-01 | 0.459 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 3.472476e-01 | 0.459 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.472476e-01 | 0.459 | 0 | 0 |
| Defective DHDDS causes RP59 | R-HSA-4755609 | 3.472476e-01 | 0.459 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 1.106467e-01 | 0.956 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 1.106467e-01 | 0.956 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.631031e-01 | 0.788 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.166977e-01 | 0.933 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.674431e-01 | 0.776 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.164360e-01 | 0.665 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.164360e-01 | 0.665 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.886074e-01 | 0.540 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.886074e-01 | 0.540 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 2.886074e-01 | 0.540 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.886074e-01 | 0.540 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 4.132833e-01 | 0.384 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.132833e-01 | 0.384 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.132833e-01 | 0.384 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.132833e-01 | 0.384 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.132833e-01 | 0.384 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.132833e-01 | 0.384 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.443275e-01 | 0.612 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.443275e-01 | 0.612 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.443275e-01 | 0.612 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.443275e-01 | 0.612 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 2.099303e-01 | 0.678 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.099303e-01 | 0.678 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.275733e-01 | 0.485 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.275733e-01 | 0.485 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.275733e-01 | 0.485 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.275733e-01 | 0.485 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.591779e-01 | 0.798 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.322160e-01 | 0.634 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.342627e-01 | 0.872 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.342627e-01 | 0.872 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.185611e-01 | 0.926 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.185611e-01 | 0.926 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.899763e-01 | 0.721 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.550416e-01 | 0.593 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 3.014721e-01 | 0.521 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.659388e-01 | 0.437 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.659388e-01 | 0.437 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 4.726421e-01 | 0.325 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.726421e-01 | 0.325 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.726421e-01 | 0.325 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.726421e-01 | 0.325 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.726421e-01 | 0.325 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.726421e-01 | 0.325 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.061720e-01 | 0.686 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.061720e-01 | 0.686 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.319143e-01 | 0.880 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.940020e-01 | 0.712 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.605261e-01 | 0.794 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.303365e-01 | 0.481 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.303365e-01 | 0.481 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.399280e-01 | 0.620 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.034267e-01 | 0.394 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 2.779895e-01 | 0.556 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.779895e-01 | 0.556 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.779895e-01 | 0.556 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.779895e-01 | 0.556 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 2.779895e-01 | 0.556 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.573925e-01 | 0.589 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 3.591648e-01 | 0.445 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.591648e-01 | 0.445 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.591648e-01 | 0.445 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 3.256374e-01 | 0.487 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.085873e-01 | 0.681 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.983276e-01 | 0.525 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.983276e-01 | 0.525 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.983276e-01 | 0.525 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.821614e-01 | 0.740 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.932502e-01 | 0.533 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.188931e-01 | 0.496 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.188931e-01 | 0.496 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.188931e-01 | 0.496 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.398222e-01 | 0.357 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.398222e-01 | 0.357 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.398222e-01 | 0.357 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.398222e-01 | 0.357 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.259986e-01 | 0.279 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.259986e-01 | 0.279 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.259986e-01 | 0.279 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.259986e-01 | 0.279 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.259986e-01 | 0.279 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.493108e-01 | 0.826 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.479791e-01 | 0.606 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.115451e-01 | 0.506 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.115451e-01 | 0.506 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.800294e-01 | 0.745 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.800294e-01 | 0.745 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.972505e-01 | 0.401 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.749627e-01 | 0.323 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.749627e-01 | 0.323 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 4.749627e-01 | 0.323 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.640852e-01 | 0.785 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.270769e-01 | 0.644 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.440037e-01 | 0.353 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.547951e-01 | 0.450 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.209213e-01 | 0.376 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 3.475984e-01 | 0.459 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.475984e-01 | 0.459 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.475984e-01 | 0.459 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.270132e-01 | 0.485 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.713419e-01 | 0.327 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 5.087297e-01 | 0.294 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 5.087297e-01 | 0.294 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 5.087297e-01 | 0.294 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 5.087297e-01 | 0.294 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 5.087297e-01 | 0.294 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 5.087297e-01 | 0.294 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.739594e-01 | 0.241 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.739594e-01 | 0.241 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.739594e-01 | 0.241 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.739594e-01 | 0.241 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.739594e-01 | 0.241 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.739594e-01 | 0.241 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.647256e-01 | 0.438 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.772219e-01 | 0.423 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.445411e-01 | 0.463 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.434685e-01 | 0.353 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.921127e-01 | 0.407 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.677260e-01 | 0.434 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.068583e-01 | 0.391 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.927808e-01 | 0.406 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 4.227689e-01 | 0.374 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 4.227689e-01 | 0.374 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.931205e-01 | 0.405 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.902850e-01 | 0.310 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 5.410415e-01 | 0.267 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.410415e-01 | 0.267 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 4.574027e-01 | 0.340 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.240621e-01 | 0.281 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 5.240621e-01 | 0.281 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.126526e-01 | 0.290 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.126526e-01 | 0.290 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 5.126526e-01 | 0.290 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.126526e-01 | 0.290 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.126526e-01 | 0.290 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.040025e-01 | 0.298 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 5.040025e-01 | 0.298 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.148906e-01 | 0.288 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.148906e-01 | 0.288 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.148906e-01 | 0.288 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.493117e-01 | 0.260 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.718468e-01 | 0.243 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.559596e-01 | 0.255 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.561509e-01 | 0.255 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.551468e-01 | 0.256 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 6.011198e-01 | 0.221 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 6.011198e-01 | 0.221 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.011198e-01 | 0.221 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.802567e-01 | 0.236 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 5.973504e-01 | 0.224 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 5.973504e-01 | 0.224 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.846387e-01 | 0.233 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.872983e-01 | 0.231 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.872983e-01 | 0.231 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.872983e-01 | 0.231 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.872983e-01 | 0.231 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.872983e-01 | 0.231 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 5.971146e-01 | 0.224 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 6.056563e-01 | 0.218 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.024575e-01 | 0.220 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.151539e-01 | 0.211 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.960415e-01 | 0.529 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.853358e-01 | 0.732 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.012372e-01 | 0.521 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.896225e-01 | 0.538 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.115451e-01 | 0.506 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.400737e-01 | 0.468 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 5.126526e-01 | 0.290 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.664581e-01 | 0.436 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.559596e-01 | 0.255 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.389458e-01 | 0.268 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.234580e-01 | 0.373 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.583725e-01 | 0.800 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.342627e-01 | 0.872 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.021183e-01 | 0.396 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.377720e-01 | 0.471 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 5.255470e-01 | 0.279 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.345580e-01 | 0.272 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.727404e-01 | 0.564 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.399280e-01 | 0.620 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.807719e-01 | 0.419 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.154915e-01 | 0.937 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.899763e-01 | 0.721 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.332025e-01 | 0.363 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.498827e-01 | 0.602 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.099303e-01 | 0.678 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.980522e-01 | 0.303 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.674431e-01 | 0.776 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.802567e-01 | 0.236 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.386462e-01 | 0.358 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.018605e-01 | 0.520 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.092659e-01 | 0.679 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.670195e-01 | 0.246 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.342627e-01 | 0.872 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.318813e-01 | 0.274 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.322160e-01 | 0.634 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.550416e-01 | 0.593 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.396187e-01 | 0.469 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.675032e-01 | 0.330 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 5.983196e-01 | 0.223 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.410415e-01 | 0.267 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.716901e-01 | 0.243 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.275740e-01 | 0.894 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.303365e-01 | 0.481 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.728954e-01 | 0.762 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.972505e-01 | 0.401 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.183371e-01 | 0.497 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.400737e-01 | 0.468 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.983196e-01 | 0.223 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.233185e-01 | 0.909 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.034267e-01 | 0.394 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 3.495235e-01 | 0.457 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.242957e-01 | 0.906 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.749627e-01 | 0.323 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.737534e-01 | 0.241 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 3.772219e-01 | 0.423 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.899763e-01 | 0.721 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.285063e-01 | 0.891 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 2.443275e-01 | 0.612 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.659388e-01 | 0.437 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.396187e-01 | 0.469 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.434685e-01 | 0.353 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.148906e-01 | 0.288 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.401954e-01 | 0.267 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.115451e-01 | 0.506 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.623763e-01 | 0.441 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.720583e-01 | 0.764 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.883004e-01 | 0.725 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.821636e-01 | 0.740 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 2.727404e-01 | 0.564 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.659388e-01 | 0.437 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.382737e-01 | 0.623 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.782932e-01 | 0.555 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.392772e-01 | 0.621 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.188931e-01 | 0.496 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.259986e-01 | 0.279 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.749627e-01 | 0.323 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.814071e-01 | 0.551 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.440037e-01 | 0.353 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.087297e-01 | 0.294 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.675032e-01 | 0.330 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.061955e-01 | 0.514 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.011198e-01 | 0.221 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.685220e-01 | 0.245 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.579481e-01 | 0.588 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.443616e-01 | 0.352 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 4.713419e-01 | 0.327 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 4.958311e-01 | 0.305 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.166977e-01 | 0.933 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.240621e-01 | 0.281 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.884692e-01 | 0.230 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.662670e-01 | 0.331 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.662670e-01 | 0.331 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.526132e-01 | 0.816 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 3.014721e-01 | 0.521 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.140623e-01 | 0.503 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.664914e-01 | 0.331 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.408086e-01 | 0.851 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.474742e-01 | 0.831 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.238081e-01 | 0.650 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.227689e-01 | 0.374 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.068574e-01 | 0.391 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.000077e-01 | 0.699 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 5.768218e-01 | 0.239 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.521131e-01 | 0.345 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.135996e-01 | 0.945 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 5.730410e-01 | 0.242 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.248897e-01 | 0.488 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.720583e-01 | 0.764 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.720583e-01 | 0.764 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.899763e-01 | 0.721 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.228383e-01 | 0.652 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 3.303365e-01 | 0.481 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.573925e-01 | 0.589 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.878054e-01 | 0.411 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.259986e-01 | 0.279 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.259986e-01 | 0.279 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.259986e-01 | 0.279 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 4.161243e-01 | 0.381 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 3.377720e-01 | 0.471 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.233279e-01 | 0.373 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.420566e-01 | 0.355 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.971146e-01 | 0.224 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.673160e-01 | 0.435 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.787307e-01 | 0.422 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.261289e-01 | 0.370 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 4.173921e-01 | 0.379 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.797637e-01 | 0.745 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.727404e-01 | 0.564 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.342627e-01 | 0.872 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.434078e-01 | 0.843 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.591838e-01 | 0.445 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.779895e-01 | 0.556 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.873377e-01 | 0.542 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.395189e-01 | 0.855 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.117156e-01 | 0.291 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.111988e-01 | 0.954 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.659259e-01 | 0.780 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.005799e-01 | 0.397 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.940703e-01 | 0.712 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.676334e-01 | 0.776 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.103625e-01 | 0.677 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.103625e-01 | 0.677 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.892840e-01 | 0.723 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.659388e-01 | 0.437 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.259986e-01 | 0.279 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.897442e-01 | 0.538 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.410415e-01 | 0.267 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.745715e-01 | 0.561 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.144576e-01 | 0.502 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.638907e-01 | 0.334 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 4.228613e-01 | 0.374 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 6.151539e-01 | 0.211 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.650050e-01 | 0.438 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.112963e-01 | 0.291 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.322160e-01 | 0.634 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.153455e-01 | 0.938 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.614143e-01 | 0.792 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 5.410415e-01 | 0.267 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.507845e-01 | 0.455 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 1.720583e-01 | 0.764 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.146268e-01 | 0.941 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.493916e-01 | 0.603 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.878054e-01 | 0.411 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.802567e-01 | 0.236 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.234580e-01 | 0.373 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.456820e-01 | 0.837 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.166977e-01 | 0.933 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.659388e-01 | 0.437 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.713419e-01 | 0.327 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.125832e-01 | 0.213 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.400737e-01 | 0.468 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 1.659259e-01 | 0.780 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.389458e-01 | 0.268 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.540778e-01 | 0.343 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.702047e-01 | 0.328 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 1.443545e-01 | 0.841 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.308097e-01 | 0.637 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.034848e-01 | 0.394 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 4.745334e-01 | 0.324 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.920583e-01 | 0.717 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.351356e-01 | 0.869 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.351356e-01 | 0.869 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.737842e-01 | 0.563 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.737842e-01 | 0.563 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.737842e-01 | 0.563 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.737842e-01 | 0.563 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.381347e-01 | 0.860 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.381347e-01 | 0.860 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.472476e-01 | 0.459 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.472476e-01 | 0.459 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.472476e-01 | 0.459 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.285063e-01 | 0.891 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 2.493916e-01 | 0.603 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.164360e-01 | 0.665 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.132833e-01 | 0.384 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.275733e-01 | 0.485 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.742971e-01 | 0.759 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.659388e-01 | 0.437 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.659388e-01 | 0.437 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.659388e-01 | 0.437 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.087050e-01 | 0.680 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.034267e-01 | 0.394 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.392772e-01 | 0.621 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.878054e-01 | 0.411 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 3.604392e-01 | 0.443 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 3.972505e-01 | 0.401 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.749627e-01 | 0.323 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.749627e-01 | 0.323 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.739594e-01 | 0.241 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.739594e-01 | 0.241 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.115086e-01 | 0.675 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.434685e-01 | 0.353 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.410415e-01 | 0.267 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.544659e-01 | 0.342 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.969821e-01 | 0.304 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 5.718468e-01 | 0.243 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.499340e-01 | 0.260 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.626003e-01 | 0.250 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 4.516947e-01 | 0.345 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.000077e-01 | 0.699 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.973814e-01 | 0.303 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.240100e-01 | 0.281 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.198274e-01 | 0.377 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.830294e-01 | 0.316 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.382737e-01 | 0.623 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.617682e-01 | 0.250 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.273349e-01 | 0.278 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.456820e-01 | 0.837 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.259699e-01 | 0.900 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.011198e-01 | 0.221 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.741243e-01 | 0.324 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.487368e-01 | 0.828 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.087297e-01 | 0.294 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.544659e-01 | 0.342 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 5.240621e-01 | 0.281 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.736391e-01 | 0.760 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.892840e-01 | 0.723 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.550416e-01 | 0.593 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.018605e-01 | 0.520 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 4.034267e-01 | 0.394 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 2.983276e-01 | 0.525 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.940703e-01 | 0.712 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.702047e-01 | 0.328 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.732524e-01 | 0.242 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.591648e-01 | 0.445 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 6.067515e-01 | 0.217 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.972505e-01 | 0.401 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.972505e-01 | 0.401 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.190871e-01 | 0.659 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.770139e-01 | 0.321 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.661973e-01 | 0.779 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.146268e-01 | 0.941 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.166977e-01 | 0.933 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 2.573925e-01 | 0.589 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.259986e-01 | 0.279 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.547951e-01 | 0.450 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.507845e-01 | 0.455 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.739594e-01 | 0.241 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.739594e-01 | 0.241 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.236122e-01 | 0.281 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.237199e-01 | 0.650 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.631031e-01 | 0.788 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.034267e-01 | 0.394 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.284973e-01 | 0.483 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.886074e-01 | 0.540 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.760296e-01 | 0.559 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.675032e-01 | 0.330 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.261592e-01 | 0.370 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.812922e-01 | 0.419 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.957540e-01 | 0.708 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.675032e-01 | 0.330 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.275167e-01 | 0.894 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.038999e-01 | 0.517 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.425631e-01 | 0.465 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.317765e-01 | 0.635 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.325499e-01 | 0.274 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.399280e-01 | 0.620 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.737842e-01 | 0.563 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.103625e-01 | 0.677 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.132833e-01 | 0.384 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.275740e-01 | 0.894 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.726421e-01 | 0.325 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.726421e-01 | 0.325 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.168001e-01 | 0.933 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.782932e-01 | 0.555 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.238081e-01 | 0.650 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.878054e-01 | 0.411 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.398222e-01 | 0.357 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.259986e-01 | 0.279 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.041011e-01 | 0.517 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.161243e-01 | 0.381 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.209213e-01 | 0.376 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.739594e-01 | 0.241 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.739594e-01 | 0.241 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.969821e-01 | 0.304 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.971146e-01 | 0.224 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.633743e-01 | 0.579 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.211653e-01 | 0.283 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.270132e-01 | 0.485 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.980522e-01 | 0.303 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.051624e-01 | 0.392 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.962550e-01 | 0.707 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.146268e-01 | 0.941 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.106467e-01 | 0.956 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.717285e-01 | 0.566 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.686354e-01 | 0.433 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.980522e-01 | 0.303 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 5.973504e-01 | 0.224 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.425631e-01 | 0.465 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.208620e-01 | 0.494 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.918971e-01 | 0.228 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.132833e-01 | 0.384 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.638907e-01 | 0.334 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.737534e-01 | 0.241 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.190871e-01 | 0.659 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.750393e-01 | 0.426 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.085208e-01 | 0.216 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.148906e-01 | 0.288 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.473602e-01 | 0.459 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 2.493916e-01 | 0.603 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 1.674431e-01 | 0.776 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.886074e-01 | 0.540 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.726421e-01 | 0.325 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.303365e-01 | 0.481 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.259986e-01 | 0.279 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.259986e-01 | 0.279 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 4.047750e-01 | 0.393 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.739594e-01 | 0.241 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.973504e-01 | 0.224 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.961348e-01 | 0.529 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 5.040025e-01 | 0.298 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.189889e-01 | 0.660 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 4.034267e-01 | 0.394 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.713419e-01 | 0.327 | 0 | 0 |
| Depurination | R-HSA-73927 | 5.236122e-01 | 0.281 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.345580e-01 | 0.272 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.047750e-01 | 0.393 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.945043e-01 | 0.531 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.393015e-01 | 0.268 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.472476e-01 | 0.459 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.303365e-01 | 0.481 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.398222e-01 | 0.357 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.259986e-01 | 0.279 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.749627e-01 | 0.323 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 3.812922e-01 | 0.419 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.980522e-01 | 0.303 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.410415e-01 | 0.267 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.718468e-01 | 0.243 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.011198e-01 | 0.221 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.011198e-01 | 0.221 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.971146e-01 | 0.224 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.574027e-01 | 0.340 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 6.011198e-01 | 0.221 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.734240e-01 | 0.428 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.797319e-01 | 0.745 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.034267e-01 | 0.394 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.034267e-01 | 0.394 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.493117e-01 | 0.260 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.631031e-01 | 0.788 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 4.398222e-01 | 0.357 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 4.227689e-01 | 0.374 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.420566e-01 | 0.355 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.768218e-01 | 0.239 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.420566e-01 | 0.355 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.751830e-01 | 0.560 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.739594e-01 | 0.241 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.434685e-01 | 0.353 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.737534e-01 | 0.241 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.087297e-01 | 0.294 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.479791e-01 | 0.606 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.718468e-01 | 0.243 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 5.167168e-01 | 0.287 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 5.345580e-01 | 0.272 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.259986e-01 | 0.279 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.737534e-01 | 0.241 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.159365e-01 | 0.210 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.170700e-01 | 0.210 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.170700e-01 | 0.210 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.170700e-01 | 0.210 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.170700e-01 | 0.210 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.170700e-01 | 0.210 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.170700e-01 | 0.210 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.187771e-01 | 0.208 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.200756e-01 | 0.208 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.208154e-01 | 0.207 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.276398e-01 | 0.202 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.288551e-01 | 0.201 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.288551e-01 | 0.201 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.288551e-01 | 0.201 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.288551e-01 | 0.201 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.288551e-01 | 0.201 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.288551e-01 | 0.201 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.288551e-01 | 0.201 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.288551e-01 | 0.201 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.288551e-01 | 0.201 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.288551e-01 | 0.201 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 6.306452e-01 | 0.200 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 6.306452e-01 | 0.200 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 6.306452e-01 | 0.200 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 6.319830e-01 | 0.199 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.324004e-01 | 0.199 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.330904e-01 | 0.199 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.330904e-01 | 0.199 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.358994e-01 | 0.197 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 6.358994e-01 | 0.197 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.358994e-01 | 0.197 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.358994e-01 | 0.197 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.391821e-01 | 0.194 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.391821e-01 | 0.194 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 6.419107e-01 | 0.193 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.419107e-01 | 0.193 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 6.419107e-01 | 0.193 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.461137e-01 | 0.190 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 6.465282e-01 | 0.189 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.465282e-01 | 0.189 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.473008e-01 | 0.189 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.491372e-01 | 0.188 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.497670e-01 | 0.187 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.497670e-01 | 0.187 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.497670e-01 | 0.187 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.550641e-01 | 0.184 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.558206e-01 | 0.183 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.558206e-01 | 0.183 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.558206e-01 | 0.183 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.558206e-01 | 0.183 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 6.558206e-01 | 0.183 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.558206e-01 | 0.183 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.558206e-01 | 0.183 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.558206e-01 | 0.183 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.558206e-01 | 0.183 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.558206e-01 | 0.183 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 6.558206e-01 | 0.183 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.558206e-01 | 0.183 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.558206e-01 | 0.183 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.558206e-01 | 0.183 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.582786e-01 | 0.182 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.583045e-01 | 0.182 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.628454e-01 | 0.179 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.628454e-01 | 0.179 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.628454e-01 | 0.179 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.716000e-01 | 0.173 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.721759e-01 | 0.173 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 6.735945e-01 | 0.172 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.797717e-01 | 0.168 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.797717e-01 | 0.168 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.797717e-01 | 0.168 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.797717e-01 | 0.168 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 6.816463e-01 | 0.166 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.828763e-01 | 0.166 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.828763e-01 | 0.166 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.828763e-01 | 0.166 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.858542e-01 | 0.164 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.868238e-01 | 0.163 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.906518e-01 | 0.161 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.906518e-01 | 0.161 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.906518e-01 | 0.161 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.906518e-01 | 0.161 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.906518e-01 | 0.161 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.906518e-01 | 0.161 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.906518e-01 | 0.161 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.906518e-01 | 0.161 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.906518e-01 | 0.161 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.906518e-01 | 0.161 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.906518e-01 | 0.161 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.906518e-01 | 0.161 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.906518e-01 | 0.161 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.906518e-01 | 0.161 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.921616e-01 | 0.160 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.938454e-01 | 0.159 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 6.996233e-01 | 0.155 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.996233e-01 | 0.155 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.020060e-01 | 0.154 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.020060e-01 | 0.154 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.029844e-01 | 0.153 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.029844e-01 | 0.153 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 7.030133e-01 | 0.153 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 7.030133e-01 | 0.153 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 7.030133e-01 | 0.153 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.030133e-01 | 0.153 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 7.030133e-01 | 0.153 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.030133e-01 | 0.153 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 7.030133e-01 | 0.153 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 7.030133e-01 | 0.153 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 7.030133e-01 | 0.153 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.030133e-01 | 0.153 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.051631e-01 | 0.152 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.058750e-01 | 0.151 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 7.064209e-01 | 0.151 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 7.178445e-01 | 0.144 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 7.197241e-01 | 0.143 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.197241e-01 | 0.143 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.202423e-01 | 0.143 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.202423e-01 | 0.143 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.215300e-01 | 0.142 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.219600e-01 | 0.141 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.219600e-01 | 0.141 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.219600e-01 | 0.141 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.219600e-01 | 0.141 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.219600e-01 | 0.141 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.219600e-01 | 0.141 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.219600e-01 | 0.141 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.219600e-01 | 0.141 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.219600e-01 | 0.141 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.219600e-01 | 0.141 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.219600e-01 | 0.141 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.219600e-01 | 0.141 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.239016e-01 | 0.140 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.239016e-01 | 0.140 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.239016e-01 | 0.140 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.239016e-01 | 0.140 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.244063e-01 | 0.140 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.244063e-01 | 0.140 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.248326e-01 | 0.140 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.248326e-01 | 0.140 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.248326e-01 | 0.140 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.255166e-01 | 0.139 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.312512e-01 | 0.136 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.339913e-01 | 0.134 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 7.369851e-01 | 0.133 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.369851e-01 | 0.133 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 7.374804e-01 | 0.132 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.390117e-01 | 0.131 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.390117e-01 | 0.131 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.393523e-01 | 0.131 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.431521e-01 | 0.129 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.452792e-01 | 0.128 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.452792e-01 | 0.128 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.452792e-01 | 0.128 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.452792e-01 | 0.128 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.452792e-01 | 0.128 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.452792e-01 | 0.128 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.476802e-01 | 0.126 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 7.501012e-01 | 0.125 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.501012e-01 | 0.125 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.501012e-01 | 0.125 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.501012e-01 | 0.125 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.501012e-01 | 0.125 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.501012e-01 | 0.125 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.501012e-01 | 0.125 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.501012e-01 | 0.125 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.501012e-01 | 0.125 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.501012e-01 | 0.125 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.501012e-01 | 0.125 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.501012e-01 | 0.125 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.514826e-01 | 0.124 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 7.515789e-01 | 0.124 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.525108e-01 | 0.123 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.540882e-01 | 0.123 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.551772e-01 | 0.122 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.600015e-01 | 0.119 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.629033e-01 | 0.118 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.644076e-01 | 0.117 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.644076e-01 | 0.117 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.644076e-01 | 0.117 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 7.651672e-01 | 0.116 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.654079e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 7.655419e-01 | 0.116 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 7.655419e-01 | 0.116 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 7.655419e-01 | 0.116 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.655419e-01 | 0.116 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 7.699727e-01 | 0.114 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.736702e-01 | 0.111 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.742932e-01 | 0.111 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.753956e-01 | 0.110 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.753956e-01 | 0.110 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 7.753956e-01 | 0.110 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.753956e-01 | 0.110 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.753956e-01 | 0.110 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.753956e-01 | 0.110 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.773269e-01 | 0.109 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.788842e-01 | 0.109 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.788842e-01 | 0.109 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.807027e-01 | 0.108 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 7.845558e-01 | 0.105 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.845558e-01 | 0.105 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.845558e-01 | 0.105 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.845558e-01 | 0.105 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.854707e-01 | 0.105 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.856447e-01 | 0.105 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.858112e-01 | 0.105 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 7.876363e-01 | 0.104 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.887647e-01 | 0.103 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 7.916177e-01 | 0.101 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.916177e-01 | 0.101 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.916177e-01 | 0.101 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.916177e-01 | 0.101 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.925945e-01 | 0.101 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.962133e-01 | 0.099 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.976447e-01 | 0.098 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.981311e-01 | 0.098 | 0 | 0 |
| Endosomal/Vacuolar pathway | R-HSA-1236977 | 7.981311e-01 | 0.098 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.981311e-01 | 0.098 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.981311e-01 | 0.098 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 7.981311e-01 | 0.098 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.981311e-01 | 0.098 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.981311e-01 | 0.098 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.981311e-01 | 0.098 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.981311e-01 | 0.098 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 7.981311e-01 | 0.098 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.985791e-01 | 0.098 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.989406e-01 | 0.097 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.989406e-01 | 0.097 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.989406e-01 | 0.097 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 7.989406e-01 | 0.097 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.989406e-01 | 0.097 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.001839e-01 | 0.097 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 8.023852e-01 | 0.096 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 8.037559e-01 | 0.095 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 8.043766e-01 | 0.095 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.045503e-01 | 0.094 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 8.108979e-01 | 0.091 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.118295e-01 | 0.091 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 8.118295e-01 | 0.091 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 8.118295e-01 | 0.091 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.144647e-01 | 0.089 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.144647e-01 | 0.089 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.144647e-01 | 0.089 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 8.144647e-01 | 0.089 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 8.144647e-01 | 0.089 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.153134e-01 | 0.089 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.153134e-01 | 0.089 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.185664e-01 | 0.087 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 8.185664e-01 | 0.087 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 8.185664e-01 | 0.087 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.185664e-01 | 0.087 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.185664e-01 | 0.087 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.185664e-01 | 0.087 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.185664e-01 | 0.087 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.185664e-01 | 0.087 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.185664e-01 | 0.087 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 8.185664e-01 | 0.087 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.185664e-01 | 0.087 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.185664e-01 | 0.087 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.185664e-01 | 0.087 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.185664e-01 | 0.087 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.185664e-01 | 0.087 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.187156e-01 | 0.087 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.195409e-01 | 0.086 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 8.211482e-01 | 0.086 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.212222e-01 | 0.086 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.243342e-01 | 0.084 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.263060e-01 | 0.083 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.263060e-01 | 0.083 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.286011e-01 | 0.082 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.289074e-01 | 0.081 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.289074e-01 | 0.081 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.289074e-01 | 0.081 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.289074e-01 | 0.081 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 8.289074e-01 | 0.081 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.289074e-01 | 0.081 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.352683e-01 | 0.078 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.357445e-01 | 0.078 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.357445e-01 | 0.078 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.361214e-01 | 0.078 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.361214e-01 | 0.078 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.361214e-01 | 0.078 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.367474e-01 | 0.077 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 8.367502e-01 | 0.077 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.369341e-01 | 0.077 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.369341e-01 | 0.077 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.369341e-01 | 0.077 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.369341e-01 | 0.077 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 8.369341e-01 | 0.077 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.369341e-01 | 0.077 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.369341e-01 | 0.077 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.369341e-01 | 0.077 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.369341e-01 | 0.077 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.369341e-01 | 0.077 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.369341e-01 | 0.077 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.369341e-01 | 0.077 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.369341e-01 | 0.077 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.420612e-01 | 0.075 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.423287e-01 | 0.075 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.423287e-01 | 0.075 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.423287e-01 | 0.075 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.423287e-01 | 0.075 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.466632e-01 | 0.072 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.472200e-01 | 0.072 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.472200e-01 | 0.072 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.472200e-01 | 0.072 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.494403e-01 | 0.071 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.507322e-01 | 0.070 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.527149e-01 | 0.069 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.533049e-01 | 0.069 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.534433e-01 | 0.069 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.534433e-01 | 0.069 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.534433e-01 | 0.069 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.534433e-01 | 0.069 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 8.534433e-01 | 0.069 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.534433e-01 | 0.069 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.534433e-01 | 0.069 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.534433e-01 | 0.069 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 8.534433e-01 | 0.069 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.534433e-01 | 0.069 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.534433e-01 | 0.069 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.547872e-01 | 0.068 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.547872e-01 | 0.068 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.547872e-01 | 0.068 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.547872e-01 | 0.068 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.547872e-01 | 0.068 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.557960e-01 | 0.068 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.558083e-01 | 0.068 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.560630e-01 | 0.067 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.576589e-01 | 0.067 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.576589e-01 | 0.067 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.577345e-01 | 0.067 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 8.610529e-01 | 0.065 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.632975e-01 | 0.064 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.650640e-01 | 0.063 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.658371e-01 | 0.063 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 8.674676e-01 | 0.062 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.680521e-01 | 0.061 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.682820e-01 | 0.061 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.682820e-01 | 0.061 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.682820e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.682820e-01 | 0.061 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.682820e-01 | 0.061 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.682820e-01 | 0.061 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.682820e-01 | 0.061 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.682820e-01 | 0.061 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 8.682820e-01 | 0.061 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.682820e-01 | 0.061 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.682820e-01 | 0.061 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.682820e-01 | 0.061 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.684595e-01 | 0.061 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.738590e-01 | 0.059 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.755345e-01 | 0.058 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.761022e-01 | 0.057 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.766749e-01 | 0.057 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.766749e-01 | 0.057 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.770435e-01 | 0.057 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.770435e-01 | 0.057 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.808251e-01 | 0.055 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.816190e-01 | 0.055 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.816190e-01 | 0.055 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.816190e-01 | 0.055 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.816190e-01 | 0.055 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.816190e-01 | 0.055 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.816190e-01 | 0.055 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.816190e-01 | 0.055 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.816190e-01 | 0.055 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.816190e-01 | 0.055 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.816190e-01 | 0.055 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 8.853098e-01 | 0.053 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.869504e-01 | 0.052 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.888946e-01 | 0.051 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.888946e-01 | 0.051 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.934007e-01 | 0.049 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.934007e-01 | 0.049 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.936063e-01 | 0.049 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.936063e-01 | 0.049 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.936063e-01 | 0.049 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.936063e-01 | 0.049 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.936063e-01 | 0.049 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.936063e-01 | 0.049 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.936063e-01 | 0.049 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.936063e-01 | 0.049 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.936063e-01 | 0.049 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.937089e-01 | 0.049 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.961126e-01 | 0.048 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.961126e-01 | 0.048 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.961126e-01 | 0.048 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.998594e-01 | 0.046 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.998594e-01 | 0.046 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.009752e-01 | 0.045 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.027079e-01 | 0.044 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 9.043804e-01 | 0.044 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.043804e-01 | 0.044 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.043804e-01 | 0.044 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.043804e-01 | 0.044 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 9.043804e-01 | 0.044 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.043804e-01 | 0.044 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.043804e-01 | 0.044 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.043804e-01 | 0.044 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.043804e-01 | 0.044 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.045792e-01 | 0.044 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.045792e-01 | 0.044 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.045792e-01 | 0.044 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.052712e-01 | 0.043 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.066731e-01 | 0.043 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 9.071542e-01 | 0.042 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 9.090277e-01 | 0.041 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 9.090277e-01 | 0.041 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 9.123051e-01 | 0.040 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.123971e-01 | 0.040 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.132017e-01 | 0.039 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.132017e-01 | 0.039 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.140641e-01 | 0.039 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.140641e-01 | 0.039 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.140641e-01 | 0.039 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.140641e-01 | 0.039 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.140641e-01 | 0.039 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.140641e-01 | 0.039 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 9.140641e-01 | 0.039 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.140641e-01 | 0.039 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.140641e-01 | 0.039 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.173017e-01 | 0.037 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 9.176364e-01 | 0.037 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.196109e-01 | 0.036 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.196487e-01 | 0.036 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.205819e-01 | 0.036 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.208681e-01 | 0.036 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.212362e-01 | 0.036 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.226797e-01 | 0.035 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.227675e-01 | 0.035 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 9.227675e-01 | 0.035 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.227675e-01 | 0.035 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.227675e-01 | 0.035 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.227675e-01 | 0.035 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.227675e-01 | 0.035 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.227675e-01 | 0.035 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.227675e-01 | 0.035 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.246617e-01 | 0.034 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.258505e-01 | 0.033 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.262626e-01 | 0.033 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.262626e-01 | 0.033 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.262626e-01 | 0.033 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.266406e-01 | 0.033 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.266406e-01 | 0.033 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.266406e-01 | 0.033 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.266406e-01 | 0.033 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.266406e-01 | 0.033 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.305900e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.305900e-01 | 0.031 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.305900e-01 | 0.031 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.305900e-01 | 0.031 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.305900e-01 | 0.031 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.305900e-01 | 0.031 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.305900e-01 | 0.031 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.305900e-01 | 0.031 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.305900e-01 | 0.031 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.305900e-01 | 0.031 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.308022e-01 | 0.031 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.311161e-01 | 0.031 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.320242e-01 | 0.031 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.320242e-01 | 0.031 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.320242e-01 | 0.031 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.323177e-01 | 0.030 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.323921e-01 | 0.030 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 9.323921e-01 | 0.030 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.323921e-01 | 0.030 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.323921e-01 | 0.030 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.346409e-01 | 0.029 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.346409e-01 | 0.029 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.354154e-01 | 0.029 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.370416e-01 | 0.028 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.376205e-01 | 0.028 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.376205e-01 | 0.028 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.376205e-01 | 0.028 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.376205e-01 | 0.028 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.376205e-01 | 0.028 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.376205e-01 | 0.028 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.376205e-01 | 0.028 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.376205e-01 | 0.028 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.377629e-01 | 0.028 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.379381e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.380369e-01 | 0.028 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.380369e-01 | 0.028 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.380369e-01 | 0.028 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.380369e-01 | 0.028 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.382630e-01 | 0.028 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.398180e-01 | 0.027 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.398180e-01 | 0.027 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.405944e-01 | 0.027 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.417147e-01 | 0.026 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.426134e-01 | 0.026 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.426134e-01 | 0.026 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.432323e-01 | 0.025 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.432323e-01 | 0.025 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 9.432323e-01 | 0.025 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.439393e-01 | 0.025 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 9.439393e-01 | 0.025 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.439393e-01 | 0.025 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.439393e-01 | 0.025 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 9.439393e-01 | 0.025 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.439393e-01 | 0.025 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.439393e-01 | 0.025 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.439393e-01 | 0.025 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.439393e-01 | 0.025 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.454143e-01 | 0.024 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.454143e-01 | 0.024 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.454143e-01 | 0.024 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.480114e-01 | 0.023 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.480114e-01 | 0.023 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.480114e-01 | 0.023 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.480114e-01 | 0.023 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 9.480114e-01 | 0.023 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.480647e-01 | 0.023 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.496184e-01 | 0.022 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.496184e-01 | 0.022 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.496184e-01 | 0.022 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.496184e-01 | 0.022 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.496184e-01 | 0.022 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.501105e-01 | 0.022 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.501105e-01 | 0.022 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.501105e-01 | 0.022 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.509265e-01 | 0.022 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.524052e-01 | 0.021 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.538721e-01 | 0.021 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.538721e-01 | 0.021 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.547225e-01 | 0.020 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.547225e-01 | 0.020 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.547225e-01 | 0.020 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.547225e-01 | 0.020 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.547225e-01 | 0.020 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.547225e-01 | 0.020 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.559323e-01 | 0.020 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.564427e-01 | 0.019 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.564427e-01 | 0.019 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.564427e-01 | 0.019 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.573671e-01 | 0.019 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.593097e-01 | 0.018 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.593097e-01 | 0.018 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.593097e-01 | 0.018 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.593097e-01 | 0.018 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.593097e-01 | 0.018 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.601293e-01 | 0.018 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.601509e-01 | 0.018 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 9.601509e-01 | 0.018 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.601509e-01 | 0.018 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.601509e-01 | 0.018 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.601509e-01 | 0.018 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.601509e-01 | 0.018 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.606126e-01 | 0.017 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.606126e-01 | 0.017 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.634325e-01 | 0.016 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 9.634325e-01 | 0.016 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.634325e-01 | 0.016 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.634325e-01 | 0.016 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.634325e-01 | 0.016 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.634325e-01 | 0.016 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.635551e-01 | 0.016 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.635551e-01 | 0.016 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.636249e-01 | 0.016 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.649417e-01 | 0.015 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.664192e-01 | 0.015 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 9.664192e-01 | 0.015 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.666789e-01 | 0.015 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.666789e-01 | 0.015 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.666789e-01 | 0.015 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.666789e-01 | 0.015 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.666789e-01 | 0.015 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.670467e-01 | 0.015 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.671377e-01 | 0.015 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 9.671377e-01 | 0.015 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.671377e-01 | 0.015 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.671377e-01 | 0.015 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.671377e-01 | 0.015 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.673267e-01 | 0.014 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.673267e-01 | 0.014 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.674710e-01 | 0.014 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.685477e-01 | 0.014 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.685477e-01 | 0.014 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.689491e-01 | 0.014 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.695440e-01 | 0.013 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.695440e-01 | 0.013 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 9.704677e-01 | 0.013 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.704677e-01 | 0.013 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 9.704677e-01 | 0.013 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.704677e-01 | 0.013 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.704677e-01 | 0.013 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.704677e-01 | 0.013 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.704677e-01 | 0.013 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.704677e-01 | 0.013 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.704677e-01 | 0.013 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.704677e-01 | 0.013 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.721709e-01 | 0.012 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 9.734605e-01 | 0.012 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.734605e-01 | 0.012 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.734605e-01 | 0.012 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.735392e-01 | 0.012 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.736350e-01 | 0.012 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.745783e-01 | 0.011 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.745783e-01 | 0.011 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.745783e-01 | 0.011 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.745783e-01 | 0.011 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.749003e-01 | 0.011 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.750424e-01 | 0.011 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 9.761501e-01 | 0.010 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.765395e-01 | 0.010 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.766572e-01 | 0.010 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.767838e-01 | 0.010 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.767838e-01 | 0.010 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.767838e-01 | 0.010 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.775997e-01 | 0.010 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.777891e-01 | 0.010 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.785673e-01 | 0.009 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.785673e-01 | 0.009 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.785673e-01 | 0.009 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.793625e-01 | 0.009 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.807396e-01 | 0.008 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.807396e-01 | 0.008 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.809925e-01 | 0.008 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.814010e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.814010e-01 | 0.008 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.814010e-01 | 0.008 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.818951e-01 | 0.008 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.823446e-01 | 0.008 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.824990e-01 | 0.008 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.828448e-01 | 0.008 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.838764e-01 | 0.007 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.838926e-01 | 0.007 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.838926e-01 | 0.007 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.838926e-01 | 0.007 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.839065e-01 | 0.007 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.844464e-01 | 0.007 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.852228e-01 | 0.006 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.852865e-01 | 0.006 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.855837e-01 | 0.006 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.860231e-01 | 0.006 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.860231e-01 | 0.006 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.860231e-01 | 0.006 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.860231e-01 | 0.006 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.860433e-01 | 0.006 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.863633e-01 | 0.006 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.864568e-01 | 0.006 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.873426e-01 | 0.006 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.874401e-01 | 0.005 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 9.874401e-01 | 0.005 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.874401e-01 | 0.005 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.874401e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.874585e-01 | 0.005 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.877855e-01 | 0.005 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.881820e-01 | 0.005 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.887135e-01 | 0.005 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.887135e-01 | 0.005 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.888664e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.894008e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.899876e-01 | 0.004 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.907762e-01 | 0.004 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.908862e-01 | 0.004 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.908862e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.908862e-01 | 0.004 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.918104e-01 | 0.004 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.923806e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.926409e-01 | 0.003 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.926409e-01 | 0.003 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 9.926409e-01 | 0.003 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.926409e-01 | 0.003 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.926409e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.927187e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.932622e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.933872e-01 | 0.003 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.933872e-01 | 0.003 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.936303e-01 | 0.003 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.940579e-01 | 0.003 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.940676e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.941645e-01 | 0.003 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.942117e-01 | 0.003 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.942117e-01 | 0.003 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.946606e-01 | 0.002 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.946606e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.946606e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.947035e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.947035e-01 | 0.002 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.950212e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.952022e-01 | 0.002 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.954941e-01 | 0.002 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.957199e-01 | 0.002 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.961262e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.961262e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.961262e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.968724e-01 | 0.001 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.969030e-01 | 0.001 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.969439e-01 | 0.001 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.970622e-01 | 0.001 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.971128e-01 | 0.001 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.971897e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.974311e-01 | 0.001 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.974749e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.975586e-01 | 0.001 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.976254e-01 | 0.001 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.977311e-01 | 0.001 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.977591e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.977591e-01 | 0.001 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.978636e-01 | 0.001 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.979614e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.979614e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.979636e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.979636e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.979636e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.980425e-01 | 0.001 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.981273e-01 | 0.001 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.981497e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.981683e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.981872e-01 | 0.001 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.982046e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.983191e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.983227e-01 | 0.001 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.983542e-01 | 0.001 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.984731e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.986132e-01 | 0.001 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.986132e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.987498e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.988062e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.988658e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.989033e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.989617e-01 | 0.000 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.989875e-01 | 0.000 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.990363e-01 | 0.000 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.990363e-01 | 0.000 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.990855e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.991455e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.991626e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.992299e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.994198e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.994644e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.994644e-01 | 0.000 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.994674e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.994931e-01 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.995067e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.996388e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.996678e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.996697e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.996697e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.997437e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997605e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.997849e-01 | 0.000 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.997849e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998008e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998067e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998264e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.998440e-01 | 0.000 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.998666e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998937e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.998984e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999009e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999087e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.999102e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999390e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999519e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999625e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999652e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999687e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999699e-01 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.999748e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999772e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.999813e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999851e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999864e-01 | 0.000 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.999873e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999877e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999948e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999949e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999963e-01 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.999963e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999967e-01 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.999967e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999976e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999981e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999990e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999992e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999996e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999999e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999999e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |